Inflammatory diseases of the central nervous system

G6_NEUINFL

encephalomyelitis: Inflammation of the brain and the spinal cord.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — G00-G09 Cause of death: ICD-10 — G00-G09 2 out of 7 registries used, show all original rules.	2300
4. Check minimum number of events None	2300
5. Include endpoints G6_MENINGBACT G6_MENINGVIR G6_MENINGOTH G6_ADEM G6_ENCEPHBACT G6_ENCEPHOTH G6_CNSABSC G6_CNSPHLEB G6_NEUROINFSEQ	3366
6. Filter based on genotype QC (FinnGen only)	3366

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF2

NAME	G6_NEUINFL
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	G6_MENINGBACT\|G6_MENINGVIR\|G6_MENINGOTH\|G6_ADEM\|G6_ENCEPHBACT\|G6_ENCEPHOTH\|G6_CNSABSC\|G6_CNSPHLEB\|G6_NEUROINFSEQ
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	G0
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	G0
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Inflammatory diseases of the central nervous system based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	30865	14355	16249
Only index persons	25199	12176	13023
Unadjusted period prevalence (%)
Whole population	0.43	0.41	0.45
Only index persons	0.47	0.45	0.50
Median age at first event (years)
Whole population	36.98	38.34	35.46
Only index persons	33.30	35.46	31.28

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3366	1823	1543
Unadjusted period prevalence (%)	0.65	0.62	0.68
Median age at first event (years)	40.96	37.25	45.35

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3024: Matched controls
30239

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

G03.9

ICD-10 Finland

Meningitis, unspecified

3967.1

323.0

362

32099

ICD-8 Finland

Meningitis, With no organism specified as cause

+∞

323.0

335

G04.9

ICD-10 Finland

Encephalitis, myelitis and encephalomyelitis, unspecified

+∞

323.0

406

G00.9

ICD-10 Finland

Bacterial meningitis, unspecified

2682.2

269.7

257

TAB00

NOMESCO Finland

Lumbar puncture

11.1

262.0

528

564

32088

ICD-8 Finland

Meningitis, Alia definita

+∞

189.6

180

G06.1

ICD-10 Finland

Intraspinal abscess and granuloma

1829.0

172.5

166

A87.9

ICD-10 Finland

Viral meningitis, unspecified

32.9

159.7

212

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

5.2

151.1

520

1162

AA1AD

NOMESCO Finland

CT of head and brain

3.1

136.1

965

4001

G06.0

ICD-10 Finland

Intracranial abscess and granuloma

1335.0

132.3

128

A86

ICD-10 Finland

Unspecified viral encephalitis

35.9

120.9

157

G05.1*B00.4

ICD-10 Finland

Herpesviral meningoencephalitis

+∞

109.0

104

32000

ICD-8 Finland

Meningitis, H. influenzae

+∞

105.8

101

32309

ICD-8 Finland

Encephalitis, myelitis and encephalomyelitis, Unspecified

+∞

103.7

G01*A69.2

ICD-10 Finland

Meningitis (in) Lyme disease

+∞

95.3

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

7.3

91.9

231

337

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

4.9

89.7

314

694

G04.8

ICD-10 Finland

Other encephalitis, myelitis and encephalomyelitis

+∞

89.0

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

3.0

85.2

569

2169

3229X

ICD-9 Finland

Meningitis of unspecified cause, Meningitis, unspecified

+∞

82.7

G00.1

ICD-10 Finland

Pneumococcal meningitis

+∞

81.6

G02.0*B00.3

ICD-10 Finland

Herpesviral meningitis

+∞

78.5

R51.80

ICD-10 Finland

Headache

2.8

78.2

602

2498

N03AX14

ATC

levetiracetam; systemic

7.2

78.1

197

288

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.8

77.1

581

2378

G40.9

ICD-10 Finland

Epilepsy, unspecified

6.0

74.4

215

378

XA800

NOMESCO Finland

Neuropsychological investigation

4.9

70.7

244

528

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.9

60.8

1290

8415

5AB01

NOMESCO Finland

69.4

59.4

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.1

59.1

357

1249

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

8.6

58.4

131

159

R50.9

ICD-10 Finland

Fever, unspecified

2.5

58.1

521

2320

G09

ICD-10 Finland

Sequelae of inflammatory diseases of central nervous system

+∞

55.4

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

11.2

54.4

105

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.8

53.2

371

1423

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

14.7

52.9

TPH04

NOMESCO Finland

Cathetrisation of vein

2.1

52.4

677

3583

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

6.5

52.1

141

227

N03AF02

ATC

oxcarbazepine; oral

5.1

51.1

168

343

N03AX16

ATC

pregabalin; oral

2.0

48.0

739

4185

G06.2

ICD-10 Finland

Extradural and subdural abscess, unspecified

+∞

47.0

G05.1

ICD-10 Finland

Encephalitis, myelitis and encephalomyelitis in viral diseases classified elsewhere

+∞

47.0

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

6.4

47.0

128

208

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.3

46.1

248

794

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

9.2

45.1

107

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.2

44.9

524

2629

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

6.1

44.9

127

217

G05.8*M32.1

ICD-10 Finland

Encephalitis in systemic lupus erythematosus

+∞

43.8

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.8

43.0

307

1187

G05.1*J09

ICD-10 Finland

Encephalitis, myelitis and encephalomyelitis in influenza caused by certain identified influenza viruses

+∞

42.8

N03AX12

ATC

gabapentin; oral

2.2

41.6

492

2478

G01*A39.0

ICD-10 Finland

Meningococcal meningitis

+∞

40.7

R56.8

ICD-10 Finland

Other and unspecified convulsions

3.2

40.1

220

714

G03.0

ICD-10 Finland

Nonpyogenic meningitis

+∞

39.7

XF400

NOMESCO Finland

ECG with 12 standard connections

2.1

39.3

504

2623

N03AG01

ATC

valproic acid; systemic, rectal

3.0

37.3

235

838

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

5.7

37.2

110

199

N71

ICPC

Meningitis/encephalitis

131.6

36.8

G03.8

ICD-10 Finland

Meningitis due to other specified causes

+∞

36.5

B00.4

ICD-10 Finland

Herpesviral encephalitis

361.5

36.0

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.9

35.4

658

3930

AAF00

NOMESCO Finland

Ventriculostomy

12.6

34.5

G05.1*B01.1

ICD-10 Finland

Varicella encephalitis

+∞

34.4

ZX120

NOMESCO Finland

Intravenous

2.4

34.2

315

1397

N03AX18

ATC

lacosamide; systemic

11.2

34.2

H02AB06

ATC

prednisolone; systemic

1.6

33.7

1317

9777

M46.3

ICD-10 Finland

Infection of intervertebral disc (pyogenic)

25.1

33.6

M46.4

ICD-10 Finland

Discitis, unspecified

18.2

33.6

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

5.8

33.4

172

N03AB02

ATC

phenytoin; systemic

8.2

33.0

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

5.5

32.8

184

32300

ICD-8 Finland

Encephalitis, myelitis and encephalomyelitis, Encephalitis postinfectiosa

+∞

32.3

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

4.2

32.2

126

309

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

7.8

30.4

AAF25

NOMESCO Finland

Removal of shunt of ventricle of brain

31.2

30.3

G05.1*B02.0

ICD-10 Finland

Zoster encephalitis

+∞

30.3

TKC20

NOMESCO Finland

Catheterisation of bladder

2.6

29.9

228

914

G03.1

ICD-10 Finland

Chronic meningitis

+∞

29.2

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

10.4

28.9

N02AX02

ATC

tramadol; systemic, rectal

1.6

28.8

1153

8505

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

14.8

28.7

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

28.4

819

5543

WX408

NOMESCO Finland

General anesthesy, balanced

1.7

28.3

772

5144

G04.0

ICD-10 Finland

Acute disseminated encephalitis

+∞

28.2

AAM00

NOMESCO Finland

Puncture and evacuation of intracerebral abscess

+∞

28.2

G00.2

ICD-10 Finland

Streptococcal meningitis

+∞

28.2

J01MA12

ATC

levofloxacin; systemic

1.9

28.1

506

2961

J01FF01

ATC

clindamycin; systemic

1.7

28.1

777

5195

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.1

27.7

359

1857

L28

ICPC

Limited function/disability (L)

1.9

26.9

411

2266

H02AB07

ATC

prednisone; oral

1.9

26.5

411

2279

A41.9

ICD-10 Finland

Sepsis, unspecified

3.5

26.4

127

373

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.9

26.3

398

2185

A28

ICPC

Limited function/disability NOS

2.0

26.2

371

1983

3238B

ICD-9 Finland

Encephalitis, myelitis and encephalomyelitis, Other causes of encephalitis[ENCEPHALITIS (MYELITIS,ENCEPHALOMYELITIS) VIROSA]

+∞

26.1

G02.0*B02.1

ICD-10 Finland

Zoster meningitis

+∞

26.1

N03AF01

ATC

carbamazepine; oral, rectal

2.7

25.6

184

712

G91.0

ICD-10 Finland

Communicating hydrocephalus

12.3

25.5

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

4.2

25.3

234

G00.8

ICD-10 Finland

Other bacterial meningitis

+∞

25.0

G02.0

ICD-10 Finland

Meningitis in viral diseases classified elsewhere

+∞

25.0

G00.3

ICD-10 Finland

Staphylococcal meningitis

+∞

25.0

R4120

NOMESCO Finland

Occupational therapy

2.4

24.7

214

918

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.2

24.6

265

1263

J01DB01

ATC

cefalexin; oral

1.6

24.6

2340

20693

N02AA05

ATC

oxycodone; systemic

1.9

24.6

378

2086

N02BE01

ATC

paracetamol; systemic, rectal

1.6

24.5

2413

21511

JN4BD

NOMESCO Finland

Extensive body CT

2.1

24.1

303

1541

R42

ICD-10 Finland

Dizziness and giddiness

1.7

24.1

567

3600

A40.3

ICD-10 Finland

Sepsis due to Streptococcus pneumoniae

8.4

24.1

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.7

23.9

174

678

H02AB09

ATC

hydrocortisone; systemic

4.2

23.9

228

WX892

NOMESCO Finland

Monitored bed care

2.3

23.8

229

1033

B94.1

ICD-10 Finland

Sequelae of viral encephalitis

241.8

23.7

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

23.5

488

2978

SPAT1255

SPAT

Intravenous administration of medicine

2.4

23.5

209

910

N06AA09

ATC

amitriptyline; systemic

2.1

23.3

276

1370

A02BC02

ATC

pantoprazole; systemic

1.5

23.3

1736

14441

M32.0

ICD-10 Finland

Drug-induced systemic lupus erythematosus

36.6

23.0

3209X

ICD-9 Finland

Bacterial meningitis, Meningitis due to unspecified bacterium

+∞

22.9

N05CF01

ATC

zopiclone; oral

1.6

22.9

831

5905

J04AB02

ATC

rifampicin; systemic

5.6

22.6

119

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.9

22.3

143

513

J05AB11

ATC

valaciclovir; oral

1.9

22.3

367

2072

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

5.0

22.2

147

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.3

22.2

222

1024

M32.1

ICD-10 Finland

Systemic lupus erythematosus with organ or system involvement

21.5

22.1

R4150

NOMESCO Finland

Neuropsychological rehabilitation

7.1

22.1

R4110

NOMESCO Finland

Physiotherapy

1.6

22.1

721

4982

R51

ICD-10 Finland

Headache

2.5

22.0

173

705

AAM30

NOMESCO Finland

Evacuation of epidural or subdural empyema

+∞

21.9

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

6.6

21.8

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.0

21.7

287

1490

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.7

21.6

149

562

G91.1

ICD-10 Finland

Obstructive hydrocephalus

15.4

21.5

183

Kela drug reimbursment

Lamotrigin and topiramate

6.2

21.5

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

6.8

21.3

A69.2

ICD-10 Finland

Lyme disease

2.6

21.3

157

614

WX882

NOMESCO Finland

High dependency care

3.4

21.2

105

317

G51.0

ICD-10 Finland

Bell palsy

3.7

21.1

261

G02.0*B01.0

ICD-10 Finland

Varicella meningitis

+∞

20.9

N05BA09

ATC

clobazam; oral

9.1

20.6

AAF99

NOMESCO Finland

Other shunt operation on ventricle of brain or intracerebral cyst

30.2

20.5

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.7

20.3

140

527

N05BA01

ATC

diazepam; systemic, rectal

1.8

20.1

364

2118

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

6.6

19.9

G91.9

ICD-10 Finland

Hydrocephalus, unspecified

11.3

19.9

G37.9

ICD-10 Finland

Demyelinating disease of central nervous system, unspecified

7.6

19.8

G05.1*J10.8

ICD-10 Finland

Encephalitis, myelitis and encephalomyelitis in influenza caused by other identified influenza virus

+∞

19.8

G04.2

ICD-10 Finland

Bacterial meningoencephalitis and meningomyelitis, not elsewhere classified

+∞

19.8

32400

ICD-8 Finland

Late effects of intracranial abscess or pyogenic infection, Hydrocephalus acquisitus

+∞

19.8

G01

ICD-10 Finland

Meningitis in bacterial diseases classified elsewhere

+∞

19.8

G01*A32.1

ICD-10 Finland

Listerial meningitis

+∞

19.8

J01MA02

ATC

ciprofloxacin; systemic

1.5

19.8

1006

7655

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

7.3

19.7

G35

ICD-10 Finland

Multiple sclerosis

4.2

19.7

181

N03AX09

ATC

lamotrigine; oral

2.5

19.6

157

644

AA1BD

NOMESCO Finland

Extensive CT of head and brain

3.3

19.4

301

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.1

19.2

229

1139

R33

ICD-10 Finland

Retention of urine

2.2

18.9

194

902

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

18.9

1413

11551

N01

ICPC

Headache

1.9

18.9

291

1603

L04AX01

ATC

azathioprine; systemic

2.5

18.8

150

616

G02.0*A87.0

ICD-10 Finland

Enteroviral meningitis

+∞

18.8

J45.9

ICD-10 Finland

Asthma, unspecified

1.7

18.7

457

2912

6BA02

NOMESCO Finland

11.1

18.7

TAA40

NOMESCO Finland

Cathetrisation of cerebrospinal fluid through skin

23.8

18.6

XA400

NOMESCO Finland

EEG

9.0

18.6

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

18.5

503

3299

C03CA01

ATC

furosemide; systemic

1.5

18.5

647

4522

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.1

18.4

225

1133

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

18.3

939

7129

N99

ICPC

Neurological disease other

5.4

18.3

104

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.5

18.1

715

5130

NA3DG

NOMESCO Finland

Lumbar spine very extensive MRI examination with high intensity magnet

7.1

18.1

N03AE01

ATC

clonazepam; systemic

2.3

18.0

170

760

R53

ICD-10 Finland

Malaise and fatigue

1.6

18.0

532

3564

I69.0

ICD-10 Finland

Sequelae of subarachnoid haemorrhage

7.0

17.9

M03BX01

ATC

baclofen; systemic

4.3

17.9

160

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.2

17.9

180

833

A87.8

ICD-10 Finland

Other viral meningitis

+∞

17.7

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.9

17.6

290

1632

WX704

NOMESCO Finland

Intubation

2.1

17.6

204

1006

N28

ICPC

Limited function/disability (N)

4.7

17.5

131

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

4.1

17.5

168

N18

ICPC

Paralysis/weakness

4.4

17.3

142

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.7

17.0

117

442

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.0

16.9

227

1186

G44.2

ICD-10 Finland

Tension-type headache

1.7

16.9

351

2129

N05AH04

ATC

quetiapine; oral

1.6

16.9

449

2924

F05.9

ICD-10 Finland

Delirium, unspecified

4.0

16.7

171

32010

ICD-8 Finland

Meningitis, Pneumococcus

+∞

16.7

G05.1*A85.0

ICD-10 Finland

Encephalitis, myelitis or encephalomyelitis (in) enteroviral

+∞

16.7

G03.2

ICD-10 Finland

Benign recurrent meningitis [Mollaret]

+∞

16.7

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.6

16.6

422

2711

J05AB01

ATC

aciclovir; systemic

1.6

16.5

543

3726

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.0

16.3

224

1179

N03AX11

ATC

topiramate; oral

3.1

16.2

292

AAA10

NOMESCO Finland

Biopsy through craniotomy

47.8

16.0

G96.0

ICD-10 Finland

Cerebrospinal fluid leak

21.1

16.0

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

15.9

559

3894

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

4.4

15.8

132

ZXC95

NOMESCO Finland

Use of surgical navigator

5.0

15.8

101

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

3.3

15.7

243

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.8

15.7

297

1750

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

15.6

528

3642

2AB04

NOMESCO Finland

13.0

15.6

AAM10

NOMESCO Finland

Excision of intracerebral abscess

+∞

15.6

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.8

15.6

260

1470

NAS20

NOMESCO Finland

Incision and debridement of infection of vertebra, unspecified

160.8

15.5

A06AD11

ATC

lactulose; oral

1.7

15.3

346

2146

G82.2

ICD-10 Finland

Paraplegia, unspecified

12.4

15.3

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

4.3

15.3

132

J01AA02

ATC

doxycycline; systemic

1.4

15.2

2108

18849

N29

ICPC

Neurological sympt/complt other

3.8

15.2

176

R41.0

ICD-10 Finland

Disorientation, unspecified

2.9

15.2

334

R20.2

ICD-10 Finland

Paraesthesia of skin

2.1

15.2

177

872

H53.2

ICD-10 Finland

Diplopia

2.8

15.1

358

WX730

NOMESCO Finland

Conventional respirator

3.8

15.1

167

L04AA06

ATC

mycophenolic acid; systemic

3.5

15.0

204

J01DA01

ATC

[U] cefalexin; systemic

1.4

14.9

1695

14641

N06AX21

ATC

duloxetine; oral

1.8

14.9

284

1678

T85.0

ICD-10 Finland

Mechanical complication of ventricular intracranial (communicating) shunt

15.1

14.9

109

Kela drug reimbursment

Multiple sclerosis

4.8

14.8

104

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

14.7

199

1042

WX872

NOMESCO Finland

Intensive care

2.3

14.6

142

645

3200A

ICD-9 Finland

Bacterial meningitis, Haemophilus meningitis

+∞

14.6

A39.0

ICD-10 Finland

Meningococcal meningitis

+∞

14.6

0499X

ICD-9 Finland

Other non-arthropod-borne viral diseases of central nervous system, Unspecified non-arthropod-borne viral diseases of central nervous system

11.9

14.5

M32.8

ICD-10 Finland

Other forms of systemic lupus erythematosus

14.2

14.5

R11

ICD-10 Finland

Nausea and vomiting

1.9

14.5

212

1145

ZXA00

NOMESCO Finland

Right side

1.5

14.4

651

4777

N05BA04

ATC

oxazepam; oral

1.5

14.4

625

4548

P01BA02

ATC

hydroxychloroquine; oral

1.9

14.4

217

1185

R90.8

ICD-10 Finland

Other abnormal findings on diagnostic imaging of central nervous system

5.2

14.4

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.6

14.3

409

2704

G40.10

ICD-10 Finland

Simple partial seizures

6.3

14.2

7100A

ICD-9 Finland

Diffuse diseases of connective tissue, Systemic lupus erythematosus

22.4

14.2

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.7

14.0

278

1662

B01AB05

ATC

enoxaparin; parenteral

1.4

13.9

717

5393

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.8

13.9

318

UKC02

NOMESCO Finland

Cystoscopy

1.6

13.9

365

2359

N73

ICPC

Neurological infection other

30.2

13.9

M05BA04

ATC

alendronic acid; oral

2.0

13.9

189

995

N06AX11

ATC

mirtazapine; oral

1.4

13.8

804

6185

R03AC02

ATC

salbutamol; inhalant

1.3

13.8

1363

11453

AAK00

NOMESCO Finland

Cranioplasty

17.6

13.8

N08.5*M32.1

ICD-10 Finland

Glomerular disorders in systemic lupus erythematosus

23.9

13.8

N05CD07

ATC

temazepam; oral

1.7

13.8

289

1757

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.9

13.7

196

1051

TPH07

NOMESCO Finland

Cathetrisation of artery

1.8

13.7

249

1449

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.4

13.7

728

5511

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.8

13.6

242

1398

S18

ICPC

Laceration/cut

1.4

13.6

1014

8141

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

13.6

335

2130

32308

ICD-8 Finland

Encephalitis, myelitis and encephalomyelitis, Alia definita

+∞

13.5

G00.0

ICD-10 Finland

Haemophilus meningitis

+∞

13.5

R4130

NOMESCO Finland

Speech therapy

3.1

13.5

238

I60.9

ICD-10 Finland

Subarachnoid haemorrhage, unspecified

4.3

13.5

115

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

11.5

13.3

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

13.2

1196

9891

G41.9

ICD-10 Finland

Status epilepticus, unspecified

6.7

13.2

WW400

NOMESCO Finland

Plasmaferesis

13.8

13.2

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.0

13.2

171

880

SPAT1254

SPAT

Administration of medicine

1.6

13.2

363

2376

G40.21

ICD-10 Finland

Partial epileptic seizure with cloudiness and automatism

7.6

13.1

A02BC01

ATC

omeprazole; systemic

1.4

13.1

682

5132

NA1DG

NOMESCO Finland

Cervical spine very extensive MRI examination with high intensity magnet

15.1

13.1

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

6.2

13.0

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.6

13.0

323

2058

G63.0*A69.2

ICD-10 Finland

Polyneuropathy (in) Lyme disease

28.5

12.9

R60.0

ICD-10 Finland

Localized oedema

1.7

12.9

260

1560

WX110

NOMESCO Finland

Local anesthesy

1.3

12.9

1873

16616

04599

ICD-8 Finland

Aseptic mentingitis due to enterovirus, Aseptic meningitis, unspecified

14.1

12.7

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

3.6

12.7

157

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.1

12.6

147

727

H47.1

ICD-10 Finland

Papilloedema, unspecified

6.2

12.6

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

6.1

12.4

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.9

12.3

175

937

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.3

12.3

110

481

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.7

12.3

286

1791

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

12.2

557

4075

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.0

12.2

161

835

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.6

12.2

310

1987

H04.10

ICD-10 Finland

Dry eye syndrome

1.7

12.1

235

1392

G81.9

ICD-10 Finland

Hemiplegia, unspecified

4.5

12.1

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

12.1

950

7659

AWC00

NOMESCO Finland

Reoperation of nervous system because of deep wound infection in the nervous system

18.1

12.0

N30.0

ICD-10 Finland

Acute cystitis

1.6

12.0

324

2109

B34.9

ICD-10 Finland

Viral infection, unspecified

2.7

12.0

317

G37.3

ICD-10 Finland

Acute transverse myelitis in demyelinating disease of central nervous system

21.4

12.0

N06AX16

ATC

venlafaxine; oral

1.6

11.9

354

2358

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.1

11.9

140

697

G40

ICD-10 Finland

Epilepsy

4.5

11.8

ZXA05

NOMESCO Finland

Left side

1.4

11.8

597

4457

J01CF05

ATC

flucloxacillin; systemic

2.3

11.7

102

443

P01AB01

ATC

metronidazole; oral, rectal

1.3

11.7

975

7921

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

5.5

11.6

A32.7

ICD-10 Finland

Listerial sepsis

65.2

11.6

XF600

NOMESCO Finland

Bloodpressure measurement

1.9

11.5

160

846

XCK00

NOMESCO Finland

Perimetry

1.9

11.5

162

861

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.1

11.5

128

621

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.1

11.5

125

600

B00.3

ICD-10 Finland

Herpesviral meningitis

+∞

11.5

3201A

ICD-9 Finland

Bacterial meningitis, Pneumococcal meningitis

+∞

11.5

H49.2

ICD-10 Finland

Sixth [abducent] nerve palsy

5.7

11.5

G73.7*M32.1

ICD-10 Finland

Myopathy in systemic lupus erythematosus

120.4

11.4

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.9

11.4

245

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

4.6

11.4

D64.9

ICD-10 Finland

Anaemia, unspecified

1.7

11.3

223

1332

73410

ICD-8 Finland

Diffuse diseases of connective tissue, Systemic lupus erythematosus

35.1

11.3

G41.0

ICD-10 Finland

Grand mal status epilepticus

12.7

11.1

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

11.1

270

1711

PA2BC

NOMESCO Finland

Cerebral extensive angiography with X-ray

4.6

11.1

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.3

11.0

435

G95.8

ICD-10 Finland

Other specified diseases of spinal cord

8.6

11.0

M54.5

ICD-10 Finland

Low back pain

1.3

11.0

817

6510

AWB00

NOMESCO Finland

Reoperation for superficial infection in surgery of the nervous system

13.9

11.0

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.4

10.9

399

SPAT1234

SPAT

Support of social functional capacity

2.1

10.9

119

576

H53.4

ICD-10 Finland

Visual field defects

3.3

10.8

168

G40.89

ICD-10 Finland

Other epilepsy

6.9

10.8

G82.5

ICD-10 Finland

Tetraplegia, unspecified

15.5

10.8

D80.8

ICD-10 Finland

Other immunodeficiencies with predominantly antibody defects

15.5

10.8

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

4.0

10.8

107

G61.0

ICD-10 Finland

Guillain-Barré syndrome

10.6

10.8

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

10.7

926

7542

101

Kela drug reimbursment

Anterior pituitary hypofunction

5.6

10.7

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.7

10.7

215

1291

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.2

10.6

100

453

M03BC01

ATC

orphenadrine (citrate); systemic

1.4

10.6

592

4492

Z71.8

ICD-10 Finland

Other specified counselling

1.4

10.5

601

4575

R07.4

ICD-10 Finland

Chest pain, unspecified

1.4

10.5

617

4721

J01CA04

ATC

amoxicillin; systemic

1.3

10.5

2240

20648

TAB22

NOMESCO Finland

Stoppin epidural fluid escape with coagulated blood

3.6

10.5

130

B02.1

ICD-10 Finland

Zoster meningitis

110.4

10.4

32200

ICD-8 Finland

Intracranial and intraspinal abscess, Intracerebralis

+∞

10.4

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.9

10.4

153

828

303

Kela drug reimbursment

Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)

4.3

10.4

120

Kela drug reimbursment

Hypogammaglobulinaemia

12.1

10.3

AA1AA

NOMESCO Finland

Head X-ray examination

4.5

10.2

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

10.2

380

2664

X58

ICD-10 Finland

Exposure to other specified factors

1.5

10.2

339

2318

A02BC03

ATC

lansoprazole; oral

1.4

10.2

683

5341

J06BA01

ATC

immunoglobulins, normal human, for extravascular adm.; systemic

11.3

10.0

A02BC05

ATC

esomeprazole; systemic

1.3

10.0

997

8266

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

9.1

10.0

A03FA01

ATC

metoclopramide; systemic, rectal

1.4

10.0

470

3450

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.5

9.9

303

2029

J01MA14

ATC

moxifloxacin; systemic

1.7

9.9

216

1330

R1260

NOMESCO Finland

Evaluation of communicative skills

3.4

9.9

137

AAF15

NOMESCO Finland

Ventriculoatrial shunt

12.2

9.8

H02AB04

ATC

methylprednisolone; systemic

1.5

9.8

352

2446

A46

ICD-10 Finland

Erysipelas

1.5

9.8

318

2162

H01BA02

ATC

desmopressin; nasal, systemic, sublingual

2.9

9.8

197

G50.0

ICD-10 Finland

Trigeminal neuralgia

3.1

9.8

170

G91.8

ICD-10 Finland

Other hydrocephalus

20.1

9.8

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.3

9.8

805

6493

R47.0

ICD-10 Finland

Dysphasia and aphasia

4.1

9.7

F07.1

ICD-10 Finland

Postencephalitic syndrome

55.2

9.6

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.8

9.6

160

903

B18.2

ICD-10 Finland

Chronic viral hepatitis C

3.5

9.6

124

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.0

9.6

116

584

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

4.0

9.5

N03AX22

ATC

perampanel; oral

15.1

9.5

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.3

9.5

708

5626

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.6

9.4

257

1676

N05CD08

ATC

midazolam; nasal, systemic

2.8

9.4

213

H49.0

ICD-10 Finland

Third [oculomotor] nerve palsy

7.5

9.4

3240A

ICD-9 Finland

Intracranial and intraspinal abscess, Intracranial abscess

+∞

9.4

23810

ICD-8 Finland

Neoplasm of unspecified nature of eye, brain and other parts of nervous system, Brain

+∞

9.4

I60.2

ICD-10 Finland

Subarachnoid haemorrhage from anterior communicating artery

6.2

9.4

AAK40

NOMESCO Finland

Closure of cerebrospinal fluid fistula

21.7

9.3

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

9.3

299

2028

J02AC01

ATC

fluconazole; systemic

1.3

9.3

951

7898

WX002

NOMESCO Finland

Sedation and analgesia

1.4

9.3

462

3423

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.6

9.3

251

1634

H02AB02

ATC

dexamethasone; systemic

1.6

9.3

221

1392

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.3

9.2

381

L89

ICD-10 Finland

Decubitus ulcer and pressure area

3.3

9.2

139

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.8

9.2

201

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.6

9.2

249

M01AE02

ATC

naproxen; oral, rectal

1.3

9.2

1469

12912

D43.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, supratentorial

6.0

9.2

N05AX08

ATC

risperidone; systemic

1.7

9.2

188

1136

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.7

9.1

191

1162

SPAT1216

SPAT

Assessment of functional ability

1.5

9.1

331

2304

R06.0

ICD-10 Finland

Dyspnoea

1.4

9.1

556

4270

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.0

9.1

113

577

B02.8

ICD-10 Finland

Zoster with other complications

6.7

9.1

H53.1

ICD-10 Finland

Subjective visual disturbances

1.9

9.0

140

773

L04AA01

ATC

[U] ciclosporin; systemic

3.3

9.0

136

J01FA06

ATC

roxithromycin; oral

1.3

9.0

994

8331

102

Kela drug reimbursment

Diabetes insipidus

10.0

9.0

G43.9

ICD-10 Finland

Migraine, unspecified

1.8

9.0

142

792

N07BA03

ATC

varenicline; oral

1.9

9.0

130

703

A04

ICPC

Weakness/tiredness general

1.5

9.0

302

2070

M79.6

ICD-10 Finland

Pain in limb

1.3

9.0

843

6912

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.1

8.9

441

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

3.5

8.9

116

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.8

8.9

150

854

J01FA10

ATC

azithromycin; systemic

1.3

8.9

1514

13392

C07AB07

ATC

bisoprolol; oral

1.3

8.8

1052

8901

K90

ICPC

Stroke/cerebrovascular accident

2.5

8.8

262

SPAT1167

SPAT

Insertion of urinary catheter

2.4

8.8

312

C01CA24

ATC

epinephrine; parenteral

1.8

8.7

151

868

EBA15

NOMESCO Finland

Extraction of large number of teeth

2.1

8.7

475

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.5

8.7

273

1839

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.4

8.7

283

A87.0

ICD-10 Finland

Enteroviral meningitis

50.1

8.7

B01AA03

ATC

warfarin; systemic

1.4

8.7

409

3000

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

8.6

921

7675

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.7

8.6

164

972

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.3

8.6

348

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.8

8.6

155

903

S06.0

ICD-10 Finland

Concussion

1.6

8.6

248

1643

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.0

8.6

153

G44.8

ICD-10 Finland

Other specified headache syndromes

3.4

8.6

115

E23.00

ICD-10 Finland

Panhypopituitarism

6.9

8.5

5CM18

NOMESCO Finland

6.9

8.5

JN4AD

NOMESCO Finland

Body CT examination

1.7

8.5

163

967

3451A

ICD-9 Finland

Epilepsy, Generalised convulsive epilepsy

10.0

8.5

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

8.5

1013

8561

ADB00

NOMESCO Finland

Implantation of vagus nerve stimulating device

20.1

8.5

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.9

8.4

124

676

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

5.4

8.4

157

Kela drug reimbursment

Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)

4.0

8.4

UJF32

NOMESCO Finland

Coloscopy

1.3

8.4

577

4510

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.9

8.4

118

633

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

8.4

337

2396

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

2.8

8.4

178

G05.1*J11.8

ICD-10 Finland

Encephalitis, myelitis or encephalomyelitis in suspected influenza

+∞

8.3

A03

ICPC

Fever

1.4

8.3

387

2834

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.3

8.3

321

XKC03

NOMESCO Finland

Water cystometry

2.3

8.3

310

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.6

8.3

225

1468

R03BA05

ATC

fluticasone; inhalant

1.4

8.3

427

3183

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.9

8.2

112

593

J01EA01

ATC

trimethoprim; systemic

1.3

8.2

571

4474

I60.1

ICD-10 Finland

Subarachnoid haemorrhage from middle cerebral artery

5.1

8.1

N07

ICPC

Convulsion/seizure

7.5

8.1

S97

ICPC

Chronic ulcer skin

1.9

8.1

121

661

W19

ICD-10 Finland

Unspecified fall

1.6

8.1

214

1386

A40.8

ICD-10 Finland

Other streptococcal sepsis

4.3

8.1

B02.0

ICD-10 Finland

Zoster encephalitis

17.2

8.1

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.9

8.1

107

563

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.0

8.0

461

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

1.7

8.0

178

1100

T78.4

ICD-10 Finland

Allergy, unspecified

1.9

8.0

114

612

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.9

8.0

108

572

SPAT1229

SPAT

Assessment of need for aid

1.7

8.0

166

1009

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

7.9

404

3004

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.7

7.9

149

881

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.2

7.9

337

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.7

7.9

155

925

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.3

7.9

298

N02CA01

ATC

dihydroergotamine; nasal, systemic

6.6

7.9

M00.0

ICD-10 Finland

Staphylococcal arthritis and polyarthritis

13.0

7.9

G95.9

ICD-10 Finland

Disease of spinal cord, unspecified

13.0

7.9

M03BX02

ATC

tizanidine; oral

1.2

7.9

1596

14322

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.0

7.8

503

N03AX23

ATC

brivaracetam; systemic

10.8

7.8

AAG00

NOMESCO Finland

Stereotactic intracranial biopsy

9.4

7.8

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

1.6

7.7

216

1417

J01.1

ICD-10 Finland

Acute frontal sinusitis

2.9

7.7

158

H47.2

ICD-10 Finland

Optic atrophy

5.9

7.7

N06AB04

ATC

citalopram; systemic

1.3

7.6

506

3929

Y89.9

ICD-10 Finland

Sequelae of unspecified external cause

3.8

7.6

R40.2

ICD-10 Finland

Coma, unspecified

3.8

7.6

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.8

7.6

160

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

4.2

7.6

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.6

7.6

172

1071

GBB00

NOMESCO Finland

Tracheostomy

3.3

7.6

111

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

3.6

7.5

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

2.4

7.5

245

D80.3

ICD-10 Finland

Selective deficiency of immunoglobulin G [IgG] subclasses

10.0

7.5

R55

ICD-10 Finland

Syncope and collapse

1.5

7.5

230

1544

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

4.3

7.5

A29

ICPC

General symptom/complaint other

1.5

7.5

240

1628

R1250

NOMESCO Finland

Evaluation of functional capability

2.5

7.4

230

B94.80

ICD-10 Finland

Late effects of bacterial meningitis

80.3

7.4

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.7

7.4

132

769

R52.2

ICD-10 Finland

Other chronic pain

2.1

7.4

389

PA2LT

NOMESCO Finland

Endovascular closure of extensive brain aneurysm

6.5

7.4

J01XX08

ATC

linezolid; systemic

5.0

7.4

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.3

7.4

502

3915

A41.8

ICD-10 Finland

Other specified sepsis

2.9

7.4

141

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

7.7

7.4

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.9

7.4

495

N05AH03

ATC

olanzapine; systemic

1.7

7.4

147

886

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.8

7.3

129

747

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

7.3

1216

10639

G36.9

ICD-10 Finland

Acute disseminated demyelination, unspecified

8.4

7.3

G08

ICD-10 Finland

Intracranial and intraspinal phlebitis and thrombophlebitis

+∞

7.3

I60.5

ICD-10 Finland

Subarachnoid haemorrhage from vertebral artery

+∞

7.3

32401

ICD-8 Finland

Late effects of intracranial abscess or pyogenic infection, Status postencephaliticus

+∞

7.3

79199

ICD-8 Finland

Headache

2.9

7.3

146

J96.0

ICD-10 Finland

Acute respiratory failure

3.2

7.3

109

N02AC04

ATC

dextropropoxyphene; oral

2.1

7.3

372

XKD03

NOMESCO Finland

Urethral pressure profilometry

2.5

7.2

219

NA7DM

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with 3 Tesla magnet

15.8

7.2

D33.30

ICD-10 Finland

Acoustic neuroma

5.8

7.2

WW200

NOMESCO Finland

Immunization

2.2

7.2

343

C71.10

ICD-10 Finland

Malignant tumor in frontal lobe without histology

7.3

7.2

L29

ICPC

Musculoskeletal sympt/complt other

1.7

7.2

155

954

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.4

7.2

440

3379

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

2.0

7.2

471

AAD10

NOMESCO Finland

Evacuation of chronic subdural haematoma

3.7

7.1

NA7CM

NOMESCO Finland

Spine and spinal cord extensive MRI examination with 3 Tesla magnet

20.1

7.1

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

7.1

646

5248

G93.4

ICD-10 Finland

Encephalopathy, unspecified

7.9

7.1

M46.2

ICD-10 Finland

Osteomyelitis of vertebra

12.0

7.1

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.6

7.1

159

990

N31.1

ICD-10 Finland

Reflex neuropathic bladder, not elsewhere classified

5.3

7.1

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.8

7.0

114

644

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.6

7.0

157

977

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.4

7.0

305

2204

WX722

NOMESCO Finland

PEEP

1.8

7.0

106

588

R35

ICD-10 Finland

Polyuria

1.7

7.0

136

812

XKD00

NOMESCO Finland

Uroflowmetry

1.4

6.9

318

2322

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

1.6

6.9

172

1099

M48.0

ICD-10 Finland

Spinal stenosis

1.5

6.9

245

1701

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.6

6.9

183

1190

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.4

6.9

221

ABC60

NOMESCO Finland

Decompression of cervical spinal cord

4.6

6.9

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

3.5

6.9

J13

ICD-10 Finland

Pneumonia due to Streptococcus pneumoniae

3.6

6.9

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.5

6.8

269

1906

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.4

6.8

304

2205

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

2.0

6.8

390

A85.8

ICD-10 Finland

Other specified viral encephalitis

40.1

6.8

D80.0

ICD-10 Finland

Hereditary hypogammaglobulinaemia

40.1

6.8

R07.3

ICD-10 Finland

Other chest pain

1.5

6.8

196

1299

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.6

6.8

184

1203

EBA00

NOMESCO Finland

Extraction of tooth

1.3

6.7

785

6576

ABE50

NOMESCO Finland

Occipitocervical decompression

16.7

6.7

I60.6

ICD-10 Finland

Subarachnoid haemorrhage from other intracranial arteries

16.7

6.7

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

6.7

566

4546

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.0

6.7

397

U04

ICPC

Incontinence urine

1.9

6.7

478

06599

ICD-8 Finland

Viral encephalitis, unspecified

22.6

6.7

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

2.2

6.6

305

A04AA01

ATC

ondansetron; systemic, rectal

1.7

6.6

138

844

UJF30

NOMESCO Finland

Ileoscopy through colon

1.5

6.6

209

1416

K08.3

ICD-10 Finland

Retained dental root

1.6

6.6

159

1011

Z43.0

ICD-10 Finland

Attention to tracheostomy

12.3

6.6

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.4

6.6

398

3046

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.6

6.6

144

890

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.7

6.5

139

852

G41.2

ICD-10 Finland

Complex partial status epilepticus

8.7

6.5

ZZC00

NOMESCO Finland

Graft of fascia

10.0

6.5

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.6

6.5

152

958

N06AB03

ATC

fluoxetine; oral

1.4

6.5

277

1994

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.7

6.5

158

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

1.9

6.5

455

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.2

6.5

1104

9646

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

1.9

6.5

470

G83.4

ICD-10 Finland

Cauda equina syndrome

5.3

6.5

B01AB10

ATC

tinzaparin; parenteral

1.7

6.4

133

809

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

1.8

6.4

112

646

AAE05

NOMESCO Finland

Nasoendoscopic closure of cerebrospinal fluid fistula

70.0

6.4

G43.3

ICD-10 Finland

Complicated migraine

2.6

6.4

160

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1.9

6.4

447

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.5

6.4

230

1602

G97.1

ICD-10 Finland

Other reaction to spinal and lumbar puncture

7.4

6.4

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.5

6.4

244

1721

S29

ICPC

Skin symptom/complaint other

1.4

6.4

348

2616

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

3.2

6.4

RS221

NOMESCO Finland

2.5

6.4

186

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.0

6.4

370

XLA10

NOMESCO Finland

1.8

6.3

102

574

D80.9

ICD-10 Finland

Immunodeficiency with predominantly antibody defects, unspecified

11.0

6.3

G61.9

ICD-10 Finland

Inflammatory polyneuropathy, unspecified

11.0

6.3

G40.11

ICD-10 Finland

Simple partial epileptic seizure that develops into a complex partial seizure

11.0

6.3

A40.1

ICD-10 Finland

Sepsis due to streptococcus, group B

11.0

6.3

G40.1

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

5.5

6.3

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.4

6.3

274

1983

G04BD04

ATC

oxybutynin; oral, transdermal

1.8

6.3

109

631

K59.0

ICD-10 Finland

Constipation

1.7

6.3

118

701

L08

ICPC

Shoulder symptom/complaint

1.3

6.3

401

3095

121

Kela drug reimbursment

Severe hypofunction of sexual glands

2.5

6.3

181

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

2.7

6.3

156

3238X

ICD-9 Finland

Encephalitis, myelitis and encephalomyelitis, Other causes of encephalitis[ENCEPHALITIS (MYELITIS, ENCEPHALOMYELITIS) ALIA DEF]

+∞

6.3

B01.1

ICD-10 Finland

Varicella encephalitis

+∞

6.3

G05.0*A17.8

ICD-10 Finland

Tuberculous meningoencephalitis

+∞

6.3

N16.4*M32.1

ICD-10 Finland

Renal tubulo-interstitial disorders in systemic lupus erythematosus

+∞

6.3

32408

ICD-8 Finland

Late effects of intracranial abscess or pyogenic infection, Alia definitae

+∞

6.3

N05AA02

ATC

levomepromazine; systemic

1.8

6.2

521

2133

FHL

Suntin revisio

26.7

6.2

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

3.0

6.2

112

F05.8

ICD-10 Finland

Other delirium

4.1

6.2

SPAT1262

SPAT

Handing over of treatment supplies

1.3

6.2

382

2932

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

6.2

530

4265

N06AB10

ATC

escitalopram; oral

1.3

6.2

471

3731

ZXA10

NOMESCO Finland

Bilateral

1.3

6.2

407

3157

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.6

6.1

137

854

A07AA02

ATC

nystatin; oral

1.7

6.1

125

757

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.3

6.1

379

2911

T91.3

ICD-10 Finland

Sequelae of injury of spinal cord

5.3

6.1

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.8

6.1

106

614

R01AD08

ATC

fluticasone; nasal

1.3

6.1

669

5554

PA2KT

NOMESCO Finland

Endovascular closure of brain aneurysm

7.7

6.1

NA1CM

NOMESCO Finland

Cervical spine extensive MRI examination with 3 Tesla magnet

7.7

6.1

C71.20

ICD-10 Finland

Malignant tumor in temporal lobe without histology

7.7

6.1

A02BA02

ATC

ranitidine; systemic

1.3

6.1

422

3294

S01.0

ICD-10 Finland

Open wound of scalp

1.6

6.1

157

1013

H90.4

ICD-10 Finland

Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side

1.9

6.1

473

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.3

6.1

433

3395

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.5

6.1

178

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

2.6

6.1

153

A10AE04

ATC

insulin glargine; parenteral

1.5

6.1

203

1390

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.5

6.1

190

1285

M32

ICD-10 Finland

Systemic lupus erythematosus

12.5

6.1

SPAT1211

SPAT

Application of soft bandage

1.5

6.1

197

1344

K91

ICPC

Cerebrovascular disease

2.9

6.0

114

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

1.7

6.0

112

660

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3023410) Appearance of Cerebral spinal fluid

319

267

13.09

322.10

1.8

1.6

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

280

199

15.25

311.02

1.9

1.2

mmol/l

3.1

1.9

8.68

271

189

(3016018) Differential panel - Cerebral spinal fluid

406

265

17.28

307.65

1.7

1.4

—

(3044290) Cell count panel - Cerebral spinal fluid

606

543

13.39

307.65

1.9

1.4

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

699

669

12.92

307.65

1.8

1.3

mg/l

866.5

500.7

17.21

680

632

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

370

128

32.35

307.65

1.3

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

382

119

36.08

307.65

1.3

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

237

29.91

307.65

1.3

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

346

258

14.83

307.65

1.1

1.0

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

668

591

13.85

307.65

1.7

1.2

mmol/l

3.5

3.8

4.99

631

555

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

587

591

11.82

307.65

2.0

1.4

e6/l

746.9

1442.0

0.62

478

480

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

587

591

11.82

307.65

1.9

1.4

e6/l

199.4

18.2

4.52

466

455

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

483

219

25.58

307.65

1.9

1.5

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

314

108

31.96

307.65

1.8

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

200

27.19

290.68

1.3

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

179

26.95

259.68

1.3

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

174

28.17

256.48

1.3

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

192

21.83

256.35

1.2

1.1

ng/l

364.0

326.2

0.07

101

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

176

25.73

251.12

1.3

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

166

26.81

240.57

1.3

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

152

31.16

231.95

1.2

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

158

23.97

219.72

1.2

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

206

178

12.26

202.76

1.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

145

16.42

170.20

1.1

1.0

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

204

226

9.54

168.62

1.4

1.1

mg/l

64.6

41.6

4.41

179

184

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

108

27.18

157.80

1.2

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

193

218

9.33

157.08

1.2

1.1

mg/l

375.6

271.9

2.71

174

187

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

592

1867

3.63

156.44

2.7

2.4

au/ml

30.6

21.4

0.66

120

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

188

211

9.38

153.73

1.2

1.1

—

(4027681)

171

175

10.24

149.69

1.3

1.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

551

1712

3.65

148.47

1.5

1.3

au/ml

50.4

47.8

0.05

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

33.75

144.16

1.3

1.1

—

(3023368) Bacteria identified in Blood by Culture

1321

6849

2.53

139.19

6.0

4.3

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

30.14

137.73

1.3

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

155

162

9.98

133.52

1.3

1.1

u/l

1.1

0.02

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

232

394

6.25

131.60

1.2

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

29.74

131.12

1.2

1.0

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

39.90

127.93

1.2

—

(3005719) IgG [Mass/volume] in Serum or Plasma

580

2059

3.19

125.07

3.6

2.7

g/l

10.1

10.5

1.37

546

1885

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

190

290

6.88

119.44

1.6

1.9

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

23.61

115.26

1.2

1.0

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

25.12

115.17

1.9

1.2

55.4

45.7

0.36

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

23.99

114.57

1.2

1.0

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

127

130

10.11

110.94

1.9

1.2

57.3

67.6

0.59

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

16.11

102.84

1.2

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

22.54

102.28

1.4

1.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

28.89

101.54

1.2

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

277

752

3.92

89.29

1.3

1.1

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

11.12

83.53

1.5

1.1

23.4

21.2

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1276

7722

2.05

82.08

2.8

2.1

u/l

189.0

234.4

0.87

1233

7270

(3028679) Herpes simplex virus Ab [Presence] in Serum

112

144

8.01

81.82

1.2

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

807

4109

2.27

81.04

2.0

1.8

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

780

3926

2.28

80.45

2.4

2.2

29.2

29.8

2.26

761

3812

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

168

335

5.23

79.89

6.4

mg/l

10.5

11.5

1.60

154

309

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

13.30

76.85

1.4

—

(42870588) Differential panel, method unspecified - Blood

1414

9075

1.96

75.26

9.2

6.0

—

(3011412) CD3 cells [#/volume] in Blood

143

263

5.63

74.30

2.6

2.5

e9/l

1.4

1.2

1.79

149

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

203

509

4.18

72.76

1.6

1.7

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

23.99

72.66

1.0

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

26.69

72.63

1.0

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

116

8.40

72.39

1.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

22.42

72.14

1.2

1.1

—

(3001604) Monocytes [#/volume] in Blood

1891

13524

1.91

71.17

9.2

5.9

e9/l

0.6

2.16

1680

11734

(3006315) Basophils [#/volume] in Blood

1895

13569

1.91

70.97

9.3

5.9

e9/l

0.0

0.01

1681

11777

(3006504) Eosinophils/100 leukocytes in Blood

1787

12671

1.87

67.75

9.6

6.1

2.7

2.8

0.73

1700

11843

(3022096) Basophils/100 leukocytes in Blood

1746

12290

1.87

67.75

9.7

6.1

0.6

0.7

1.23

1657

11510

(3019198) Lymphocytes [#/volume] in Blood

1920

13943

1.88

67.33

9.2

5.9

e9/l

1.9

0.24

1733

12347

(3013115) Eosinophils [#/volume] in Blood

1930

14041

1.88

67.27

9.7

6.1

e9/l

0.2

0.06

1725

12384

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

115

191

6.20

66.38

2.5

2.8

e6/l

530.3

556.9

0.17

164

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

113

187

6.22

65.46

2.6

2.8

e9/l

0.2

0.56

163

(3019069) Monocytes/100 leukocytes in Blood

1784

12746

1.85

64.97

10.0

6.4

8.6

0.15

1701

11976

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

24.53

64.79

1.2

1.0

—

(3023183) Ammonium ion [Moles/volume] in Plasma

202

549

3.85

64.70

2.7

3.0

umol/l

29.9

36.4

2.56

176

476

(3002030) Lymphocytes/100 leukocytes in Blood

1824

13139

1.85

64.51

9.6

6.1

27.3

28.4

4.12

1725

12295

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

133

265

5.18

63.22

1.6

1.9

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

2058

15475

1.85

62.44

6.8

4.8

mmol/l

6.6

6.7

0.56

1963

14426

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1643

11557

1.82

61.84

8.3

6.1

mmol/l

1.2

5.08

1522

10505

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1772

12769

1.82

61.42

9.1

6.7

mmol/l

1.2

2.62

1524

10803

(3018010) Neutrophils/100 leukocytes in Blood

1792

12961

1.82

61.31

9.3

5.9

57.7

56.9

1.79

1701

12173

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

116

210

5.68

61.26

2.4

2.7

e6/l

656.4

710.2

0.30

(3024561) Albumin [Mass/volume] in Serum or Plasma

1596

11174

1.81

60.59

6.1

4.9

g/l

34.8

35.8

9.16

1503

10412

(21494815) CD4 cells/100 lymphocytes in Specimen

123

238

5.33

60.42

2.5

2.3

46.0

42.5

0.34

(1175426) CD3 cells/100 lymphocytes in Blood

113

203

5.72

60.16

2.3

2.1

76.1

72.7

1.47

108

197

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

245

797

3.24

59.50

2.4

2.8

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

112

202

5.70

59.38

2.3

2.0

12.7

12.4

0.08

(3013650) Neutrophils [#/volume] in Blood by Automated count

2059

15613

1.82

59.36

12.6

9.1

e9/l

4.3

4.1

2.62

1843

13654

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1848

13628

1.79

57.88

7.7

6.1

umol/l

10.4

11.5

4.84

1757

12950

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

105

183

5.89

57.69

2.4

2.0

—

(3028026) IgM [Mass/volume] in Serum or Plasma

384

1618

2.55

57.62

2.2

1.8

g/l

1.3

1.4

0.29

353

1484

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

568

2843

2.20

57.50

1.9

1.7

—

(3032080) INR in Blood by Coagulation assay

1479

10239

1.79

57.28

9.0

8.9

inr

1.2

0.55

397

3015

(3042936) Bacteria identified in Isolate by Culture

686

3717

2.06

56.38

2.4

2.0

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

566

2858

2.18

55.93

1.9

1.7

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

21.25

55.89

1.3

1.1

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

234

786

3.12

53.77

3.5

1.6

g/l

0.2

2.07

218

743

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

234

819

3.00

50.01

3.5

1.5

g/l

1.2

0.18

218

773

(3033658) Prothrombin time (PT) actual/Normal

1045

6734

1.80

49.90

5.3

4.0

90.4

90.7

0.17

1024

6569

(3014148) Varicella zoster virus Ab [Titer] in Serum

143

366

4.04

49.73

1.2

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

619

3371

2.02

49.53

7.4

6.2

mmol/l

1.0

0.57

579

3139

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

219

744

3.08

49.30

1.7

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

15.17

47.68

1.4

2.0

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

12.65

46.08

1.4

2.4

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

13.10

46.00

1.5

2.1

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

391

1836

2.28

45.63

1.9

1.6

—

(3000060) B lymphocytes [#/volume] in Blood

7.95

44.71

2.3

1.9

e6/l

223.8

186.7

0.32

(3012095) Magnesium [Moles/volume] in Serum or Plasma

709

4180

1.88

44.39

4.4

3.6

mmol/l

0.8

0.83

661

3923

(3031040) Bacteria [#/volume] in Urine by Automated count

2158

17390

1.67

42.39

6.2

4.3

e6/l

5318.2

1622.9

0.52

241

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

11.76

42.08

1.3

1.2

—

(3028433) Virus identified in Specimen by Culture

7.11

41.94

1.4

1.2

—

(3006245) CD3-CD19+ cells/100 cells in Blood

103

6.62

41.69

2.5

2.1

9.9

10.6

0.18

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

10.35

41.34

1.7

1.8

—

(4062490)

109

262

4.27

41.22

1.5

1.4

—

(3002582) Erythrocytes [#/volume] in Urine

1138

7890

1.67

39.82

4.4

3.2

e6/l

36.4

89.6

2.93

906

6020

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

127

5.77

39.08

1.4

1.1

miu/ml

1666.3

1567.8

0.23

127

(3003396) Base excess in Arterial blood by calculation

521

2886

1.95

38.93

9.4

7.9

mmol/l

1.1

0.10

414

2226

(3027135) IgG subclass 1 [Mass/volume] in Serum

106

261

4.16

38.84

1.5

1.4

g/l

6.7

6.9

0.13

180

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2439

20507

1.69

38.58

11.0

7.3

u/l

78.7

77.7

0.63

2344

19361

(3024139) IgG subclass 3 [Mass/volume] in Serum

105

261

4.12

37.99

1.5

1.4

g/l

0.3

0.4

0.74

179

(3028192) IgG subclass 2 [Mass/volume] in Serum

105

261

4.12

37.99

1.5

1.4

g/l

2.8

2.9

0.34

181

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

519

2894

1.94

37.96

9.4

7.9

kpa

5.1

0.20

491

2756

(3027801) Oxygen [Partial pressure] in Arterial blood

519

2895

1.94

37.92

9.4

7.9

kpa

12.7

12.4

0.58

491

2760

(3030467) Casts [#/volume] in Urine by Automated count

1051

7223

1.66

37.58

4.3

3.1

e6/l

0.3

0.4

2.42

818

5406

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

164

552

3.07

37.44

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

164

552

3.07

37.44

1.3

—

(3020779) Urea [Moles/volume] in Serum or Plasma

434

2293

2.02

37.02

8.6

7.8

mmol/l

8.4

9.4

2.18

414

2196

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

204

782

2.71

36.69

1.4

1.3

—

(3026008) Bacteria identified in Urine by Culture

1075

7492

1.64

36.06

3.9

3.0

—

(3024869) Neuronal Ab [Presence] in Serum

10.37

36.01

1.1

—

(36304419) Bacteria [Presence] in Urine

1030

7106

1.65

35.95

4.2

3.0

—

(3026782) Osmolality of Urine

787

5070

1.72

35.57

3.6

2.7

mosm/kgh2o

538.3

551.6

0.95

689

4305

(3018095) Leukocytes [#/volume] in Urine

1276

9297

1.60

35.53

5.1

3.7

e6/l

58.8

101.3

2.19

948

6519

(3024980) IgG subclass 4 [Mass/volume] in Serum

136

427

3.28

34.88

1.6

1.7

g/l

0.6

0.8

1.81

106

323

(3007853) Bacteria identified in Skin by Aerobe culture

538

3125

1.86

34.47

2.1

1.7

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

829

5462

1.69

34.30

1.9

—

(3037467) Urinalysis macro (dipstick) panel - Urine

2216

18429

1.59

34.14

6.2

4.2

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

500

2853

1.88

33.83

4.1

4.2

u/l

246.6

246.3

0.01

469

2701

(3036481) Cortisol [Moles/volume] in Serum or Plasma

460

2558

1.92

33.66

2.6

2.1

nmol/l

349.0

372.5

1.83

432

2343

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

226

950

2.48

33.63

2.1

1.8

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1152

8275

1.60

33.59

3.0

2.6

u/l

57.1

0.00

1075

7680

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

212

869

2.54

33.27

2.6

2.4

ug/l

485.9

459.4

0.05

200

819

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

306

1475

2.18

33.13

1.7

1.6

—

(40758558) Short blood count panel - Blood

981

6802

1.62

33.01

9.0

6.8

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

696

4444

1.71

32.08

3.5

2.7

e6/l

1.1

1.2

0.24

405

2488

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

228

986

2.41

31.87

2.4

2.0

ug/l

3.6

2.1

0.38

208

871

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

258

1179

2.29

31.78

1.9

2.0

u/l

35.6

39.4

2.53

233

1053

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

186

736

2.62

31.38

1.9

2.1

mg/l

10.9

11.1

0.11

171

682

(3003181) Sodium [Moles/volume] in Urine

132

435

3.12

31.25

1.4

1.3

mmol/l

70.4

62.8

0.92

102

345

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

135

453

3.06

30.99

1.4

1.5

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

410

2258

1.93

30.74

7.9

7.5

mmol/l

1.3

1.4

0.62

392

2170

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

154

563

2.82

30.30

5.5

6.1

iu/ml

414.2

743.7

0.59

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

21.04

30.30

1.2

1.0

—

(3000850) Epithelial cells [#/volume] in Urine

810

5453

1.64

30.26

3.3

2.6

e6/l

6.1

5.9

0.16

733

4772

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

15.40

29.67

1.0

1.1

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

745

4945

1.65

29.31

3.7

3.6

ng/l

248.1

472.4

2.04

540

3683

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

198

834

2.46

29.30

4.1

1.8

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1292

9758

1.53

29.04

4.0

3.5

ng/l

33.3

47.8

1.27

881

6325

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

647

4150

1.69

29.00

3.8

2.9

e6/l

2.6

2.4

0.27

356

2207

(3018418) pH of Serum or Plasma

1039

7495

1.56

28.74

5.2

4.0

7.4

0.14

192

1456

(3009445) Proteinase 3 Ab [Units/volume] in Serum

239

1105

2.25

28.59

1.5

1.6

u/ml

18.8

18.0

—

(3013707) Erythrocyte sedimentation rate by Westergren method

2327

19912

1.55

28.58

5.6

4.0

mm/h

13.4

11.3

8.51

2209

18499

(3000991) Gas panel - Venous blood

389

2157

1.91

28.47

9.7

9.1

—

(3016502) Oxygen saturation in Arterial blood

445

2581

1.83

28.27

10.3

8.4

95.9

95.7

0.18

430

2482

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

21.12

27.66

1.1

1.0

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

7.35

27.55

1.1

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

115

378

3.11

27.36

1.8

1.9

titre

2800.0

1335.0

—

(3002032) Base excess in Venous blood by calculation

414

2374

1.85

27.23

4.8

4.1

mmol/l

1.5

2.0

1.69

353

1904

(3021447) Carbon dioxide [Partial pressure] in Venous blood

415

2393

1.84

26.79

4.7

4.0

kpa

5.8

0.90

404

2322

(3019309) Folate [Moles/volume] in Red Blood Cells

680

4523

1.63

26.17

1.9

1.8

nmol/l

1112.0

1165.9

0.86

532

3439

(3020630) Protein [Mass/volume] in Serum or Plasma

359

1996

1.89

25.97

2.7

2.6

g/l

66.1

66.5

0.39

330

1841

(3024354) Oxygen [Partial pressure] in Venous blood

356

1978

1.89

25.80

4.0

3.4

kpa

4.8

4.7

0.56

344

1917

(3044640) Blood type and Crossmatch panel - Blood

1121

8374

1.51

25.75

2.9

2.4

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

306

1617

1.98

25.73

9.4

8.3

mmol/l

24.5

24.8

0.71

299

1607

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1326

10284

1.48

25.14

2.2

1.9

pmol/l

96.4

95.8

0.15

707

5456

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

198

898

2.28

24.77

1.5

1.6

titre

185.7

280.6

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

256

1287

2.07

24.70

5.7

4.6

mmol/l

23.7

24.2

1.59

230

1171

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

5.27

24.36

2.8

3.4

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

121

439

2.82

24.18

3.7

3.2

u/ml

1082.1

1521.5

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

405

2398

1.78

23.82

10.9

8.7

g/l

120.4

122.6

1.34

393

2303

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

843

6012

1.54

23.72

1.8

mg/l

1.2

1.1

0.42

655

4510

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

133

513

2.66

23.63

1.7

1.5

—

(3037522) Nuclear Ab [Titer] in Serum

570

3720

1.64

23.41

1.5

1.3

titre

574.9

523.0

0.28

145

749

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1176

9020

1.47

23.06

4.2

3.2

u/l

37.0

34.9

0.23

1112

8576

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

13.02

22.84

1.5

1.0

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

14.08

22.78

1.3

1.0

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

114

418

2.79

22.35

4.5

5.5

umol/l

347.0

372.7

1.15

370

(21494814) CD8 cells/100 lymphocytes in Specimen

106

4.77

22.19

2.1

2.0

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

166

3.91

21.94

3.2

2.9

42.5

41.0

0.15

(3014576) Chloride [Moles/volume] in Serum or Plasma

505

3246

1.65

21.92

8.9

7.2

mmol/l

104.1

104.4

0.65

495

3168

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

253

1327

1.98

21.67

10.0

10.5

mmol/l

24.4

24.3

0.14

234

1246

(3007164) IgA [Mass/volume] in Serum or Plasma

764

5433

1.53

21.47

1.8

1.5

g/l

2.3

2.4

0.31

528

3375

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

212

1049

2.09

21.32

2.1

1.9

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1364

10884

1.43

21.10

2.6

2.3

nmol/l

76.2

0.00

1235

9871

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

222

1122

2.05

21.09

1.9

1.8

g/l

1.7

1.5

1.98

192

974

(3017143) Hepatitis C virus Ab [Presence] in Serum

521

3408

1.63

21.02

1.7

1.6

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

146

624

2.40

20.94

1.6

1.8

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

149

643

2.38

20.91

1.6

1.7

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

283

3.09

20.49

1.2

—

(3008295) Osmolality of Serum or Plasma

289

3.06

20.40

1.5

1.4

mosm/kgh2o

284.1

280.7

0.61

212

(3011397) Hemoglobin [Presence] in Urine by Test strip

837

6123

1.49

20.36

4.5

3.5

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

398

2450

1.71

20.26

2.6

2.3

g/l

0.2

0.06

372

2293

(3015171) Extractable nuclear Ab [Units/volume] in Serum

206

1029

2.07

20.20

1.4

1.2

u/ml

1.4

0.9

0.24

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2154

18704

1.42

20.14

4.3

3.1

u/l

54.0

47.3

2.72

2043

17589

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

182

872

2.15

19.90

1.7

1.6

iu/ml

0.1

0.2

0.13

168

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

4.88

19.18

2.6

2.4

u/ml

188900.0

30347.8

—

(3004588) Protein electrophoresis panel - Serum or Plasma

288

1640

1.83

19.16

2.6

2.3

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

172

820

2.16

19.05

3.2

3.3

u/ml

0.3

0.51

458

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

156

715

2.24

19.05

1.4

1.3

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

885

6625

1.46

18.91

2.5

2.2

mg/l

3.1

2.9

0.92

762

5639

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

860

6405

1.46

18.87

2.8

2.3

—

(3021589) Normoblasts [#/volume] in Blood

1471

12050

1.39

18.86

13.0

9.3

e9/l

0.0

0.85

1202

9834

(3019060) Gas panel - Arterial blood

287

1641

1.82

18.84

8.0

5.2

—

(3027945) Reticulocytes/100 erythrocytes in Blood

438

2818

1.64

18.76

2.6

2.8

1.7

1.8

0.75

388

2500

(3008152) Bicarbonate [Moles/volume] in Arterial blood

278

1581

1.83

18.57

10.9

7.2

mmol/l

24.9

24.4

1.44

261

1464

(3036489) Thrombin time

203

1042

2.01

18.47

2.4

2.3

21.5

21.3

0.08

180

914

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

393

2486

1.66

17.96

2.6

2.5

u/l

68.0

58.2

0.10

346

2143

(3024891) Influenza virus A+B Ag [Presence] in Specimen

162

773

2.15

17.91

1.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

108

432

2.55

17.89

1.3

1.1

—

(3000494) Fungus identified in Specimen by Culture

478

3176

1.59

17.88

1.6

1.5

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

265

1504

1.83

17.81

1.6

1.5

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

287

1669

1.79

17.79

4.7

3.9

kpa

5.2

0.32

268

1546

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

178

3.47

17.68

1.7

1.9

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1510

12514

1.37

17.62

4.5

4.0

—

(3009343) pH of Capillary blood

282

1647

1.78

17.22

4.8

3.9

7.4

0.07

199

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

274

1589

1.79

17.13

4.7

3.9

mmol/l

1.6

1.7

0.10

215

1178

(3023520) Reticulocytes [#/volume] in Blood

336

2066

1.70

17.08

2.5

2.7

e9/l

66.2

70.7

1.37

248

1553

(3015377) Calcium [Moles/volume] in Serum or Plasma

1097

8669

1.39

16.93

3.7

3.3

mmol/l

2.3

2.4

2.28

960

7647

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

189

3.32

16.80

1.6

—

(3035350) Ketones [Presence] in Urine by Test strip

1568

13157

1.36

16.52

4.8

3.5

estimate

0.0

0.80

278

2452

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

129

3.84

16.52

3.0

2.3

umol/l

49.8

53.1

0.34

105

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

240

1356

1.83

16.35

13.0

11.2

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

109

467

2.38

15.61

1.8

—

(3009261) Glucose [Presence] in Urine by Test strip

1575

13301

1.35

15.56

4.8

3.5

estimate

0.0

1.32

284

2419

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

104

437

2.42

15.55

1.4

1.2

u/ml

5.2

4.6

0.16

195

(3021601) Nitrite [Presence] in Urine by Test strip

1561

13167

1.35

15.54

6.6

4.8

estimate

0.0

0.50

289

2507

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

167

851

2.01

15.53

2.6

2.4

g/l

10.3

10.2

0.05

132

730

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2937

27473

1.54

15.26

24.1

13.3

mg/l

23.5

23.2

0.18

2536

21601

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

175

916

1.96

15.08

2.7

2.3

g/l

7.3

0.24

122

693

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

175

916

1.96

15.08

2.7

2.3

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

174

915

1.95

14.80

2.7

2.3

g/l

3.8

0.10

116

662

(3022217) INR in Platelet poor plasma by Coagulation assay

457

3133

1.53

14.72

24.0

23.5

inr

1.3

0.17

446

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

125

583

2.19

14.68

1.5

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

283

2.72

14.58

3.9

4.3

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

169

887

1.95

14.46

2.6

95.1

92.0

0.91

155

835

(3022313) Gas panel - Capillary blood

214

1213

1.82

14.43

4.7

3.9

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

9.49

14.32

1.6

1.3

mg/l

1.6

2.0

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

9.49

14.32

1.6

1.3

mg/l

1.5

4.8

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

9.49

14.32

1.6

1.3

mg/l

2.3

0.8

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

9.49

14.32

1.6

1.3

mg/l

2.7

3.3

0.08

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

9.49

14.32

1.6

1.3

mg/l

0.3

1.4

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

9.49

14.32

1.6

1.3

mg/l

4.0

2.3

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

9.49

14.32

1.6

1.3

mg/l

1.6

3.3

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

9.49

14.32

1.6

1.3

mg/l

2.6

5.8

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

9.49

14.32

1.6

1.3

mg/l

1.6

2.5

0.19

(1761868) Lipid panel - Serum or Plasma

806

10240

0.72

14.26

2.6

2.7

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

164

858

1.96

14.16

2.7

2.4

g/l

3.0

3.1

0.60

121

679

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

102

444

2.34

14.13

1.4

1.2

u/ml

3.3

3.9

0.16

146

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

4.45

14.00

2.3

1.9

—

(3021960) Folate [Moles/volume] in Serum or Plasma

750

5716

1.40

13.85

1.7

1.5

nmol/l

20.3

0.01

666

4931

(3047181) Lactate [Moles/volume] in Blood

152

782

1.99

13.78

9.7

6.9

mmol/l

1.4

1.3

0.53

132

670

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

8.99

13.77

1.6

1.4

mg/l

0.7

2.0

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

191

1061

1.85

13.76

4.8

4.2

mmol/l

24.9

24.8

0.19

180

991

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

295

1862

1.64

13.50

4.2

4.1

ng/l

85.2

86.3

0.07

256

1625

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

4.37

13.32

1.2

1.3

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

521

3749

1.46

13.15

2.9

2.4

g/l

2.3

0.92

493

3468

(3017181) Myelocytes/100 leukocytes in Blood

337

2217

1.58

12.99

4.9

4.3

0.9

0.18

132

630

(3021879) Hepatitis B virus core Ab [Presence] in Serum

336

2210

1.58

12.96

1.5

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

872

6875

1.36

12.96

3.0

ng/l

1211.8

1338.2

0.27

734

5822

(3004809) Band form neutrophils/100 leukocytes in Blood

400

2.34

12.81

4.2

3.7

1.4

0.03

325

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

435

3039

1.50

12.72

3.4

2.9

umol/l

7.5

8.1

0.33

361

2649

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

599

4453

1.42

12.63

1.7

1.6

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

148

780

1.94

12.54

2.8

2.5

g/l

1.5

1.0

0.52

125

688

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

166

3.10

12.50

1.3

1.2

—

(3002179) Metamyelocytes/100 leukocytes in Blood

311

2030

1.59

12.39

4.6

4.1

0.6

0.06

105

467

(3000093) Morphology [Interpretation] in Blood Narrative

227

2.76

12.33

1.4

1.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

138

715

1.97

12.29

2.1

2.3

g/l

36.4

37.7

1.11

113

623

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

152

816

1.90

12.20

3.2

2.9

g/l

3.8

3.6

1.02

146

770

(3005322) IgE [Units/volume] in Serum or Plasma

282

1806

1.61

12.16

1.4

1.3

u/ml

241.5

215.8

0.17

266

1666

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

123

615

2.04

12.11

1.3

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

134

692

1.97

12.06

2.4

2.3

g/l

0.0

0.09

118

641

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

144

765

1.92

11.93

1.6

1.2

u/ml

38.2

34.9

0.05

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

278

2.55

11.88

1.2

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

314

2.45

11.87

1.2

—

(44790048)

308

2.47

11.87

1.6

—

(44790047)

308

2.47

11.87

1.6

—

(44790049)

308

2.47

11.87

1.6

—

(44806118)

308

2.47

11.87

1.6

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

483

3494

1.45

11.77

3.0

2.5

21.0

23.5

3.07

420

3002

(3039000) Anion gap in Blood

113

555

2.07

11.69

11.4

8.2

mmol/l

11.2

11.4

0.20

102

491

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

118

589

2.04

11.68

1.4

1.6

—

(3018572) Chloride [Moles/volume] in Blood

113

556

2.07

11.63

11.4

8.2

mmol/l

105.2

105.4

0.07

102

492

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

161

896

1.84

11.56

1.4

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

332

2.38

11.43

2.4

—

(3021440) Promyelocytes/100 leukocytes in Blood

316

2116

1.54

11.24

5.0

4.3

0.2

0.1

0.51

128

582

(3022948) Iron [Moles/volume] in Serum or Plasma

547

4082

1.41

11.18

2.9

2.5

umol/l

12.1

13.6

3.92

518

3777

(3052851) Hemolysis interference index of Serum or Plasma

141

762

1.89

11.11

3.8

3.2

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

10.94

11.06

1.6

1.3

—

(3006653) Thiamine [Moles/volume] in Blood

142

3.13

10.98

1.2

1.3

nmol/l

122.8

138.6

1.72

142

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

397

2.22

10.87

1.3

1.5

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

2937

27824

1.43

10.79

25.3

15.1

mmol/l

139.3

139.7

11.07

2892

27127

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

108

539

2.04

10.73

1.5

u/ml

92.9

114.8

0.96

(3019225) pH of Specimen

357

2480

1.49

10.67

5.1

4.1

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

172

1001

1.76

10.66

8.7

5.8

1.0

0.9

1.02

161

932

(3023420) DNA double strand Ab [Units/volume] in Serum

275

2.47

10.65

2.5

1.5

iu/ml

22.4

26.4

—

(3024316) Viscosity of Plasma

8.26

10.61

1.1

1.2

mpas

1.3

1.8

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

3.75

10.57

3.7

2.7

umol/l

32.8

29.0

0.57

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

145

804

1.84

10.56

2.8

202.8

184.3

1.44

138

769

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1387

11935

1.28

10.39

3.2

2.8

ug/l

130.9

122.5

0.55

1279

11102

(40761535) Cells panel - Urine sediment

315

2149

1.51

10.27

4.5

3.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

349

2.26

10.23

1.3

1.5

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

191

1160

1.69

10.16

3.7

2.9

0.7

0.05

182

1116

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

171

1008

1.73

10.15

8.6

5.7

1.8

1.6

0.93

159

937

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

122

649

1.91

10.11

2.2

2.4

g/l

0.0

0.00

106

600

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

131

714

1.87

10.09

1.6

1.2

u/ml

5.2

8.6

0.59

122

(3017354) Segmented neutrophils/100 leukocytes in Blood

246

2.51

10.08

3.6

3.7

59.1

56.1

0.46

171

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

113

588

1.95

10.00

1.3

u/ml

275.5

264.9

0.12

356

(3048929) Epstein Barr virus Ab [Presence] in Serum

163

952

1.75

9.99

1.3

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

129

703

1.87

9.94

1.6

1.2

u/ml

10.5

3.0

0.79

(3037121) Protein [Mass/volume] in Urine

159

924

1.76

9.92

4.3

3.3

g/l

0.2

0.3

1.75

402

(3012501) Base excess in Blood by calculation

113

591

1.94

9.86

7.0

4.3

mmol/l

2.7

2.5

0.33

394

(3013290) Carbon dioxide [Partial pressure] in Blood

113

592

1.94

9.81

7.0

4.3

kpa

5.0

0.31

105

583

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

491

3675

1.39

9.78

1.7

1.8

1.5

1.38

432

3280

(40760888) Immunoglobulin light chains.free panel - Serum

105

537

1.99

9.77

3.1

3.5

—

(3019150) Specific gravity of Urine by Refractometry

728

5793

1.33

9.77

5.2

3.9

kg/l

1.0

0.43

125

822

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

120

643

1.90

9.75

2.3

2.4

g/l

0.0

0.00

105

599

(3027315) Oxygen [Partial pressure] in Blood

113

594

1.93

9.72

7.0

4.4

kpa

8.5

8.6

0.36

105

584

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

107

552

1.97

9.72

1.4

—

(4198724)

132

3.05

9.65

1.6

3.5

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

2936

27912

1.40

9.64

25.3

15.2

mmol/l

4.0

0.62

2883

27164

(3024928) Oxygen saturation in Venous blood

107

554

1.96

9.62

3.9

3.5

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

296

2.32

9.54

1.8

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

130

720

1.84

9.53

3.5

3.4

mg/l

58.8

65.5

0.09

109

580

(3019832) Treponema pallidum Ab [Presence] in Serum

392

2837

1.43

9.45

1.5

1.7

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

369

2.17

9.37

1.7

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

129

718

1.83

9.32

3.5

3.4

mg/l

45.7

62.3

0.77

107

576

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

126

699

1.83

9.20

3.5

3.4

ratio

7.4

1.6

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

360

2.17

9.12

1.4

1.6

—

(1616796) Gas panel - Central venous blood

107

565

1.92

9.10

5.9

3.7

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

107

565

1.92

9.10

1.6

1.2

u/ml

3.8

3.6

—

(3025159) Blasts/100 leukocytes in Blood

291

2003

1.50

9.09

4.9

4.4

0.7

0.4

0.17

113

497

(3010421) pH of Blood

127

710

1.82

9.05

6.7

4.0

7.4

0.41

105

582

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

235

2.45

9.03

1.4

1.8

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

235

2.45

9.03

1.4

1.8

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

235

2.45

9.03

1.4

1.8

—

(3016038) Potassium [Moles/volume] in Urine

165

2.75

9.02

1.3

1.2

mmol/l

36.4

34.9

0.12

150

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

106

567

1.90

8.69

1.6

1.2

u/ml

23.6

42.4

1.14

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

109

590

1.88

8.62

1.2

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

305

2143

1.47

8.60

2.4

2.3

ug/l

5.9

7.2

0.91

262

1905

(3035637) Corticotropin [Mass/volume] in Plasma

330

2.18

8.56

1.5

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

131

2.92

8.53

1.2

1.1

u/l

23.1

16.9

0.49

111

(4035726)

316

2239

1.45

8.53

1.5

1.4

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

368

2684

1.42

8.48

4.3

3.3

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

585

4598

1.33

8.44

3.5

3.0

mmol/l

2.4

0.03

500

4031

(3016650) Hepatitis A virus Ab [Presence] in Serum

472

1.95

8.20

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

146

2.76

8.12

8.4

7.1

u/ml

3624.5

53.8

0.47

(3027273) Bicarbonate [Moles/volume] in Venous blood

184

1176

1.60

8.05

3.6

3.3

mmol/l

25.6

25.3

0.61

178

1138

(3020891) Body temperature

165

1027

1.64

8.04

7.2

4.4

—

(40768804) Tissue Pathology biopsy report

1244

10800

1.24

7.99

2.1

2.0

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

137

2.79

7.90

1.2

1.1

u/l

93.6

88.5

0.11

119

(3026493) Urate [Moles/volume] in Serum or Plasma

838

6962

1.27

7.89

3.1

2.6

umol/l

1872.7

4726.7

2.23

739

6095

(3051651) Icteric interference index of Serum or Plasma

160

2.65

7.86

4.1

3.3

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

536

1.87

7.86

5.3

3.9

57.8

57.6

0.05

536

(3017732) Neutrophils [#/volume] in Blood

270

1886

1.47

7.85

3.2

2.8

e9/l

4.0

4.1

0.54

195

1513

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

214

2.40

7.83

1.2

titre

330.0

147.0

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

127

2.85

7.79

1.9

1.6

iu/ml

394595.7

1452875.0

—

(3008536) Aspergillus sp Ab [Presence] in Serum

3.88

7.69

1.5

2.1

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2254

20884

1.24

7.65

4.5

3.9

pmol/l

14.8

14.7

0.43

2083

19133

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

141

2.71

7.50

1.4

2.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

141

2.71

7.50

1.4

2.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

141

2.71

7.50

1.4

2.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

141

2.71

7.50

1.4

2.1

—

(3051611) Lipemic interference index of Serum or Plasma

258

2.23

7.38

3.8

3.3

—

(3043409) Potassium [Moles/volume] in Arterial blood

130

780

1.69

7.32

6.4

4.0

mmol/l

3.8

3.9

1.20

123

728

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

126

751

1.70

7.27

1.9

1.8

—

(3037756) Immunofixation for Serum or Plasma

501

1.86

7.20

1.5

1.6

—

(4268621)

294

2.13

7.17

2.5

2.3

—

(3028626) Oxygen [Partial pressure] in Capillary blood

110

634

1.76

7.16

5.4

3.8

kpa

8.8

8.4

1.16

101

585

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

169

2.50

7.08

1.1

1.0

ng/l

351.5

287.4

0.43

109

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

477

1.87

7.00

1.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

114

2.82

6.83

1.5

2.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

114

2.82

6.83

1.5

2.3

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

115

2.80

6.73

1.5

2.3

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2028

18700

1.21

6.71

3.3

3.1

—

(3025941) Bacteria identified in Stool by Culture

227

1582

1.47

6.70

1.3

1.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

168

2.46

6.67

1.1

1.0

ng/l

641.4

728.9

0.65

108

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2627

24893

1.25

6.58

5.3

4.6

mu/l

1.8

2.1

1.88

2433

22994

(3020191) Ethanol [Moles/volume] in Serum or Plasma

227

2.22

6.47

1.2

1.6

promille

0.7

1.3

2.38

175

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

171

2.41

6.43

1.1

1.0

ng/l

40.8

43.4

0.16

106

(40758292) HTLV I+II Ab panel - Serum

3.93

6.43

1.2

1.4

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

6.13

6.43

1.7

3.8

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

277

2024

1.40

6.33

2.7

2.8

ng/l

187.2

189.9

0.03

247

1820

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

192

2.31

6.26

1.3

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

192

2.31

6.26

1.3

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

192

2.31

6.26

1.3

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

312

2.01

6.18

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

312

2.01

6.18

1.5

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

258

2.11

6.17

2.5

2.6

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

313

2.00

6.12

1.5

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

194

2.28

6.12

1.3

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

194

2.28

6.12

1.3

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

266

2.09

6.10

1.1

1.0

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2686

25580

1.25

6.05

19.1

12.2

ml/min/173m2

85.3

83.9

2.41

2335

21076

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

195

2.27

6.05

1.3

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

560

1.73

6.05

5.9

3.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

315

1.99

6.02

1.5

—

(40760892) CBC W Ordered Manual Differential panel - Blood

735

6186

1.24

5.97

6.6

4.5

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

424

1.83

5.89

1.3

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

136

2.51

5.85

1.5

1.4

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

652

5437

1.25

5.74

1.6

1.7

pmol/l

48809977.1

27948978.7

0.30

588

4587

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

246

2.09

5.72

1.2

u/l

58.6

59.5

0.04

171

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

207

2.19

5.68

1.2

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

3.11

5.61

1.9

1.5

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

139

2.46

5.61

1.5

1.4

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

232

1681

1.41

5.59

3.2

3.3

pmol/l

4.4

4.5

1.05

202

1498

(1001926) Buprenorphine [Presence] in Urine by Screen method

149

992

1.53

5.55

4.3

2.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

311

1.95

5.54

1.5

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

105

648

1.64

5.41

4.5

3.3

mmol/l

24.5

24.8

0.30

564

(3024522) Salmonella sp identified in Specimen by Organism specific culture

314

1.93

5.39

1.5

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

565

1.68

5.36

2.6

2.2

g/l

132.9

131.1

0.22

415

(3039162) Centromere protein B Ab [Units/volume] in Serum

337

1.89

5.31

1.8

1.3

u/ml

85.7

51.2

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1154

10250

1.19

5.31

5.2

3.6

—

(3042631) Mycobacterium sp identified in Specimen

332

1.88

5.22

2.1

2.8

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

119

765

1.58

5.20

1.5

1.4

ug/g

250.9

291.1

1.30

435

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

392

1.80

5.12

1.2

—

(40767503) Oxygen content in Capillary blood by calculation

534

1.68

5.12

3.3

2.5

16.9

16.6

0.20

268

(3009508) Creatinine [Moles/volume] in Urine

931

8138

1.20

5.07

4.0

3.3

mmol/l

7.6

7.8

0.47

789

6930

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

109

692

1.59

5.03

1.4

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

291

2227

1.34

5.01

2.4

2.3

nmol/l

12.7

13.1

0.33

259

1995

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

117

759

1.56

4.93

5.8

4.3

mg/l

1.6

1.5

0.94

110

707

(40768443) Skin Pathology biopsy report

156

1078

1.47

4.89

1.2

—

(3011985) Renin [Units/volume] in Plasma

327

1.85

4.81

1.4

mu/l

54.6

54.4

0.01

290

(3007566) Smooth muscle Ab [Titer] in Serum

116

759

1.55

4.72

1.2

1.3

titre

111.2

93.3

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

138

938

1.49

4.71

1.2

1.3

miu/ml

173.8

220.1

0.83

444

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

248

1872

1.35

4.69

1.2

iu/ml

143.6

151.6

0.10

692

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

212

2.04

4.62

1.3

1.2

u/ml

97.7

31.9

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

3.50

4.61

2.1

1.7

—

(40765096) Chromosome analysis panel by Banding

2.76

4.61

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

421

1.73

4.59

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

136

927

1.49

4.58

1.7

—

(3021901) Oxygen saturation in Capillary blood

459

1.69

4.58

4.3

2.8

—

(3013336) Amino acids [Identifier] in Serum or Plasma

8.20

4.56

3.0

4.8

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.98

4.55

2.7

2.1

umol/l

19.5

16.5

0.45

(3000475) Leukocytes [#/volume] in Synovial fluid

608

1.60

4.51

1.8

1.7

e6/l

12475.2

13324.8

0.10

440

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

214

2.02

4.51

1.3

1.2

u/ml

13.0

42.4

—

(3034426) Prothrombin time (PT)

2.59

4.46

1.3

—

(3040151) Glucose [Moles/volume] in Capillary blood

285

1.87

4.45

4.3

5.8

mmol/l

7.6

7.4

0.10

244

(40768446) Kidney Pathology biopsy report

105

2.49

4.45

2.0

1.7

—

(3029937) Albumin [Presence] in Urine by Test strip

814

7112

1.19

4.37

5.5

3.9

estimate

0.0

1.28

270

2414

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

183

2.09

4.36

1.1

1.2

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

7.52

4.35

1.1

1.0

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

436

1.69

4.33

1.1

—

(3048689) Calprotectin [Mass/mass] in Stool

418

3422

1.25

4.30

2.6

2.4

ug/g

168.4

131.0

0.71

340

2741

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

253

1.91

4.30

4.3

3.7

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

205

2.01

4.26

1.5

1.7

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

455

1.66

4.21

1.2

1.1

iu/ml

18666.6

1213.0

0.44

112

(3004616) Nuclear Ab [Presence] in Serum

335

1.77

4.19

1.4

1.3

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

122

830

1.49

4.18

1.3

1.2

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

3.42

4.18

1.1

1.2

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

127

873

1.47

4.14

1.7

1.4

u/l

9.8

9.2

0.22

106

709

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

122

2.31

4.10

1.9

1.7

nmol/l

4.7

8.2

0.37

104

(4306422)

430

1.66

4.02

1.2

—

(21494755) Public health laboratory ask at order entry panel

238

3059

0.76

4.00

1.4

1.3

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

183

2.03

3.98

1.8

1.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

204

1.97

3.96

1.3

1.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

565

1.57

3.95

1.5

1.3

—

(42529406) Shigella sp [Presence] in Stool by Culture

122

842

1.47

3.91

1.3

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

121

836

1.46

3.87

1.3

1.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.78

3.85

1.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

552

4711

1.21

3.80

1.4

1.3

iu/ml

22.9

30.6

1.18

166

1475

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

12.02

3.76

1.2

mg/l

2.5

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

108

2.32

3.75

1.4

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

108

2.32

3.75

1.4

1.5

—

(3023419) Bacteria identified in Sputum by Culture

332

1.73

3.75

3.3

2.7

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

244

1.86

3.74

2.0

2.4

—

(40761511) CBC panel - Blood by Automated count

2952

28716

1.23

3.69

19.6

12.4

—

(3021788) Differential panel - Synovial fluid

465

1.60

3.66

1.6

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

5.64

3.65

1.2

5.0

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

2.70

3.65

1.4

1.2

—

(3016879) Cocaine [Presence] in Urine

160

1177

1.38

3.63

4.2

2.5

—

(3022621) pH of Urine by Test strip

221

1708

1.31

3.61

3.4

2.7

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2996

29207

1.23

3.55

15.3

9.9

u/l

28.1

27.1

1.69

2922

28277

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

10.01

3.49

6.3

5.8

—

(4010399)

238

1868

1.29

3.48

1.4

—

(40768797) Stomach Pathology biopsy report

435

3660

1.22

3.47

1.2

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

119

2.19

3.44

1.8

2.8

umol/l

90.0

153.6

0.71

(21494890) Protein electrophoresis panel - 24 hour Urine

244

1.81

3.44

1.9

2.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

616

5360

1.18

3.41

1.7

1.5

—

(3012516) Albumin [Mass/volume] in Urine

828

7388

1.16

3.33

3.7

3.3

mg/l

1000.9

352.0

1.78

557

4720

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

314

1.70

3.32

1.6

58.1

59.6

0.09

203

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

128

2.12

3.29

3.1

1.8

umol/l

29.8

29.7

0.01

123

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

102

2.26

3.28

1.3

1.2

—

(3027008) Opiates [Presence] in Urine

168

1269

1.34

3.25

4.1

2.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

170

1.95

3.23

1.2

1.1

ratio

1.1

1.0

0.16

(3000764) Benzodiazepines [Presence] in Urine

167

1262

1.34

3.22

4.1

2.4

—

(36660697) Celiac disease serology panel - Serum

274

2213

1.26

3.21

1.2

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

700

6185

1.17

3.20

1.3

u/ml

2.4

1.6

0.42

162

1655

(3003434) Protein [Mass/volume] in Pleural fluid

295

1.71

3.19

1.3

1.4

g/l

30.1

31.9

0.37

263

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.86

3.19

5.4

6.1

—

(3028300) Cannabinoids [Presence] in Urine

168

1274

1.34

3.17

4.2

2.4

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

263

2122

1.26

3.11

2.9

2.5

ml/min/173m2

67.7

68.5

0.05

107

810

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

145

2.01

3.09

1.0

1.2

u/l

9.7

11.8

0.54

135

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

3.08

1.1

1.0

—

(3020393) Adenovirus Ag [Presence] in Stool

3.24

3.05

1.8

1.5

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.69

3.05

1.4

1.2

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

3.46

3.04

1.2

1.0

—

(3044009) aPTT.lupus sensitive (LA screen)

3.46

3.04

1.3

1.2

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

247

1.75

3.03

1.3

1.4

e6/l

43352.6

95886.8

0.71

147

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

257

2077

1.26

3.01

6.0

3.7

mmol/l

1.2

3.57

235

1810

(3045414) Leukocytes [Presence] in Urine

157

1190

1.33

2.99

2.0

1.8

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

263

1.72

2.99

2.9

4.6

u/ml

27.6

83.7

1.13

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.35

2.98

1.3

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

375

3160

1.21

2.96

8.8

6.7

—

(3012441) Differential panel - Pleural fluid

234

1.76

2.96

1.4

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

176

1.88

2.95

1.1

nmol/l

0.1

4.2

—

(3027944) Amphetamines [Presence] in Urine

163

1247

1.32

2.92

3.6

2.4

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

121

2.07

2.92

1.0

1.1

u/ml

9.3

7.2

—

(3019174) dRVVT (LA screen)

3.34

2.90

1.2

1.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2548

24603

1.15

2.90

6.0

5.4

mmol/mol

39.8

39.4

0.90

2373

22944

(3023199) Leukocytes [#/volume] in Pleural fluid

281

1.68

2.89

1.3

1.4

e6/l

2434.9

1868.2

0.27

200

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

141

1857

0.75

2.88

1.3

1.4

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

115

2.09

2.88

1.0

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

4.10

2.88

1.4

1.3

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

102

2.16

2.86

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

171

1.88

2.85

1.4

1.6

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

415

1.55

2.85

1.1

1.2

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

137

1.98

2.79

1.3

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

137

1.98

2.79

1.3

1.6

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

8.34

2.75

1.0

—

(4015189)

2.43

2.70

2.5

2.8

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

105

2.10

2.68

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

143

1089

1.33

2.67

2.2

2.3

u/l

1805.5

4454.4

2.02

414

(3045788) Cell count panel - Pleural fluid

227

1.73

2.66

1.4

1.5

—

(3013293) Extractable nuclear Ab [Presence] in Serum

2.80

2.64

2.5

1.8

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

312

1.61

2.64

2.4

2.2

mg/l

19.7

23.6

0.34

(3013512) EKG study

806

7297

1.14

2.58

4.2

3.7

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

193

1.77

2.54

1.9

1.8

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

170

1337

1.29

2.53

2.7

2.3

—

(3011288) Drugs identified in Urine by Screen method

117

873

1.35

2.52

5.5

3.6

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

157

1.85

2.52

1.9

1.5

u/l

6.5

6.3

0.02

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

108

2.04

2.51

2.4

2.6

—

(3045424) Erythrocytes [Presence] in Urine

462

1.48

2.48

1.5

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

414

1.51

2.46

1.5

1.4

u/l

22.8

25.0

0.24

337

(3044889) 12 lead EKG panel

1957

18680

1.11

2.45

3.9

3.6

—

(3020682) Albumin/Creatinine [Ratio] in Urine

851

7756

1.13

2.44

4.5

4.0

mg/mmol

17.2

9.1

2.23

569

4969

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

311

1.58

2.43

1.4

pmol/l

336.4

289.7

0.37

246

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

5.01

2.40

1.0

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

227

2749

0.81

2.38

1.7

—

(3032057) Clostridioides difficile [Presence] in Stool

2.51

2.35

2.2

2.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

147

1.84

2.32

1.4

1.6

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

147

1.84

2.32

1.4

1.6

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

116

878

1.33

2.30

3.2

3.6

u/ml

421.8

4736.9

0.77

100

751

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.86

2.30

1.1

1.0

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

119

1.94

2.30

1.3

1.1

iu/ml

299.4

200.9

0.36

119

(3052592) Norovirus Ag [Presence] in Stool

2.69

2.27

1.9

1.5

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.69

2.27

1.3

1.6

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

193

1.72

2.26

1.3

1.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.16

2.24

3.2

2.8

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.16

2.24

3.2

2.8

—

(3028717) Thiamine [Mass/volume] in Blood

3.11

2.22

1.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

359

1.51

2.22

1.7

1.5

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

240

1.63

2.22

1.4

1.3

e6/l

82382.1

94199.7

0.05

164

(3019977) pH of Arterial blood

135

1.86

2.22

2.9

7.4

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

180

1.73

2.18

1.1

1.0

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

670

1.37

2.18

1.7

1.9

iu/l

4.8

4.6

0.06

244

(3041096) Erythrocytes [Presence] in Urine by Automated

796

7272

1.12

2.18

4.5

3.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

137

1072

1.29

2.16

1.8

1.6

mu/l

288.6

295.7

0.15

127

966

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

196

1.69

2.15

1.3

1.2

—

(3000330) Specific gravity of Urine by Test strip

157

1251

1.27

2.15

4.9

3.3

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

3.69

2.15

1.7

4.8

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

294

2502

1.19

2.14

3.5

4.1

ug/l

8.1

20.5

1.30

223

2024

(3006922) Hepatitis E virus Ab [Presence] in Serum

189

1.70

2.13

1.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

506

1.41

2.07

2.7

3.4

u/ml

120.4

853.6

0.82

470

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

2.91

2.07

1.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.03

2.05

1.8

1.6

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

104

1.93

2.00

3.4

2.6

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

2.82

2.00

4.2

6.6

ug/min

35.0

45.3

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

489

0.61

1.99

1.7

1.5

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

3.34

1.96

1.4

2.0

—

(3029075) Extractable nuclear Ab panel - Serum

2.08

1.96

1.0

—

(3047189) Immunofixation for 24 hour Urine

112

1.88

1.96

1.4

1.8

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

359

3133

1.16

1.95

4.5

4.3

31.8

0.03

254

2188

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.36

1.94

1.3

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.36

1.94

1.3

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.36

1.94

1.3

1.2

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

4.55

1.94

1.0

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

3.75

1.93

1.5

1.7

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

3.75

1.93

1.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

497

1.40

1.92

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

497

1.40

1.92

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

180

1.67

1.91

1.1

1.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

404

3563

1.15

1.91

2.3

2.1

—

(3042733) HLA Ab [Presence] in Serum

106

1.89

1.90

6.3

5.1

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

158

1.71

1.88

3.3

2.9

93.7

96.9

0.16

151

(3029396) Erythrocyte agglutination [Presence] in Blood

2.16

1.88

2.6

2.9

—

(3035933) Granulocytes/100 leukocytes in Blood

1.94

1.84

1.9

1.6

—

(3004451) EKG impression Narrative

122

1.81

1.84

1.1

1.3

—

(3014051) Protein [Presence] in Urine by Test strip

596

1.35

1.83

2.3

2.0

—

(3009677) Dengue virus Ab [Presence] in Serum

4.17

1.82

1.2

1.0

—

(3008037) Lactate [Moles/volume] in Venous blood

529

1.37

1.80

4.1

3.0

mmol/l

1.6

0.17

513

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

365

3212

1.15

1.79

2.2

2.0

—

(3044941) Cell count panel - Synovial fluid

411

1.42

1.79

1.8

1.4

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

320

1.48

1.78

1.2

1.3

—

(3002385) Erythrocyte distribution width [Ratio]

2372

23040

1.10

1.76

26.4

16.2

13.8

13.6

5.71

2336

22532

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.50

1.74

10.6

8.2

mmol/l

4.2

6.7

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

290

1.49

1.72

3.4

2.5

—

(3024471) HLA-A [Type]

103

1.85

1.71

1.0

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.88

1.70

1.3

1.1

—

(3014271) Vancomycin [Susceptibility]

111

1.81

1.68

3.6

2.9

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

104

1.83

1.67

1.3

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

426

1.39

1.66

1.8

1.6

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

497

4490

1.13

1.65

1.3

u/ml

5.8

10.3

1.70

182

1813

(4024509)

228

1.54

1.64

1.8

1.5

—

(3035880) pH of Pleural fluid

120

1.75

1.62

1.1

1.3

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.15

1.61

1.1

1.2

—

(3022145) Colonoscopy Study observation

333

2939

1.15

1.59

1.5

1.3

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

106

1.80

1.58

1.2

1.0

—

(3025130) Human papilloma virus identified in Specimen

363

1.41

1.57

2.1

1.8

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

562

1.32

1.53

2.0

2.2

nmol/l

0.9

0.11

472

(44806071)

2.43

1.53

1.0

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

307

1.44

1.51

1.2

1.3

nmol/l

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

124

1.70

1.47

4.1

3.8

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.88

1.44

1.3

1.2

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

2.25

1.40

2.2

2.9

—

22.5

—

(40757373) Influenza virus identified in Isolate

2.08

1.38

1.7

1.8

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

2.08

1.38

1.1

1.2

mg/l

1.5

200.7

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.94

1.36

1.0

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

583

1.29

1.35

1.5

1.3

—

(3017704) Immunofixation for Urine

143

1.61

1.35

1.5

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

558

0.71

1.33

1.9

1.7

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.78

1.32

1.1

1.2

—

(3011648) Oxygen content in Venous blood

233

1.46

1.31

2.1

3.5

10.6

11.4

0.57

233

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

225

1.47

1.31

1.2

1.4

titre

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

217

1.48

1.30

1.0

1.3

u/ml

0.2

0.5

0.75

(3026389) Candida sp identified in Specimen by Organism specific culture

343

1.38

1.30

1.1

1.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

174

1495

1.17

1.24

1.3

1.4

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

2.00

1.23

1.1

—

6.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.91

1.22

1.0

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.63

1.21

1.0

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

124

1.62

1.20

1.2

—

(4211845)

124

1.62

1.20

3.1

2.9

—

(21494434) Karyotype in Bone marrow

230

1.44

1.19

1.2

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

2.31

1.18

6.2

7.3

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

109

1.65

1.18

1.1

1.2

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.00

1.16

1.4

1.3

—

(3024932) HLA-DR beta [Type]

103

1.65

1.12

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.34

1.12

2.4

2.6

—

(3038515) Glucose [Moles/volume] in Venous blood

494

1.28

1.11

4.5

3.1

mmol/l

7.8

7.4

0.40

482

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

234

1.41

1.10

1.2

1.4

—

(40768806) Pleura Pathology biopsy report

234

1.41

1.10

1.5

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

168

1.49

1.09

1.4

3.5

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

2.38

1.09

1.0

u/ml

0.5

5.2

—

(3006270) Folate [Moles/volume] in Blood

218

1.43

1.09

1.4

1.1

nmol/l

365.6

377.6

0.13

199

(3023323) Follitropin [Units/volume] in Serum or Plasma

157

1359

1.16

1.05

1.5

1.4

iu/l

27.1

26.6

0.07

134

1147

(3027035) Albumin [Mass/time] in 24 hour Urine

2.12

1.05

1.7

1.2

—

640.5

—

(3030313) Adrenal Ab [Titer] in Serum

2.27

1.03

1.2

1.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2632

26729

0.93

1.01

4.3

4.2

mmol/l

1.4

1.89

2430

24876

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

1.88

1.00

1.0

1.2

ng/l

125.5

75.8

—

(3014891) Appearance of Pleural fluid

2.00

1.00

1.7

1.6

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

164

1.47

0.99

1.2

—

(3009542) Hematocrit [Volume Fraction] of Blood

2607

25641

1.07

0.98

23.5

14.2

39.4

40.2

3.92

1928

19200

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

1.80

0.96

3.1

3.0

—

(40757494) Bilirubin.total [Moles/volume] in Blood

141

1.49

0.94

2.2

2.1

umol/l

49.8

32.3

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

121

1037

1.17

0.94

1.7

—

(3002619) Bacteria identified in Specimen by Culture

1.77

0.94

1.4

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1104

0.84

0.93

1.7

mg/l

5.0

4.1

0.21

777

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.22

0.93

1.0

1.1

—

(3017509) Phencyclidine [Presence] in Urine

2.22

0.93

1.0

1.4

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

633

0.79

0.92

1.6

1.5

—

(3035320) C reactive protein [Mass/volume] in Body fluid

192

1.41

0.92

2.1

2.2

—

(3050794) Legionella sp Ab [Presence] in Serum

2.14

0.91

1.0

—

(3006462) Nitrate [Presence] in Urine

110

1.55

0.90

3.3

3.0

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

2.07

0.89

3.5

2.9

mg/l

1.3

1.0

—

(3042517) Benzodiazepines panel - Urine

2.07

0.89

11.5

2.3

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

869

8285

1.07

0.89

4.5

ug/l

2.4

2.6

0.20

790

7484

(3045142) Bone marrow Pathology biopsy report

297

1.32

0.89

1.3

1.4

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

458

1.25

0.87

3.5

3.2

nmol/l

0.8

0.95

352

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

621

1.21

0.87

2.1

2.4

ug/min

70.9

124.2

1.18

385

(3000492) Spirometry study

302

2764

1.10

0.87

1.6

1.4

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

229

1.36

0.86

1.5

1.4

mmol/l

11.1

12.2

0.32

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

161

1.43

0.86

1.0

1.4

u/l

5.8

8.3

0.99

135

(3008898) HLA-B27 [Presence]

121

1047

1.16

0.86

1.1

—

(3044927) Protein electrophoresis panel - Urine

248

1.33

0.83

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

113

1304

0.86

0.83

1.5

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

205

1.37

0.83

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

364

0.74

0.81

1.3

mmol/l

6.6

7.2

0.38

265

(3009871) Measles virus Ab [Titer] in Serum

1.55

0.81

1.4

1.6

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

189

1.38

0.80

1.9

1.8

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.73

0.79

1.1

1.3

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

198

0.66

0.76

2.2

1.6

mmol/l

7.8

7.6

—

118

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.70

0.75

26.4

8.4

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

108

1.48

0.73

2.6

4.3

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2659

26914

0.94

0.73

4.3

4.2

mmol/l

4.6

4.7

1.59

2474

25188

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.75

0.71

7.7

10.2

—

(3051593) INR in Capillary blood by Coagulation assay

1.51

0.69

8.0

14.8

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

337

1.25

0.69

2.6

2.3

umol/l

9.0

6.9

0.53

239

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2703

27331

0.94

0.68

4.8

4.6

mmol/l

2.7

2.8

2.29

2491

25407

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.53

0.68

1.7

2.0

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

429

1.22

0.67

1.2

u/l

61.5

40.2

0.23

369

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

1.57

0.65

1.7

1.3

31.8

29.9

—

(3049717) Cytology report of Urine Cyto stain

105

924

1.14

0.64

2.6

2.5

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.72

0.64

1.8

umol/l

86.4

46.2

—

(3048879) Bone marrow aspiration report

1.59

0.61

2.0

2.3

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

214

1969

1.09

0.60

2.3

2.1

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

0.00

0.60

0.0

1.6

—

0.5

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.54

0.59

1.3

—

(3018001) Oat IgE Ab [Units/volume] in Serum

0.00

0.59

0.0

1.0

—

0.3

—

(1761482) Bacteria [#/volume] in Urine by Culture

612

1.16

0.59

7.0

4.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.51

0.58

1.3

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.72

0.57

1.5

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.72

0.57

1.2

1.4

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

1.67

0.56

2.3

3.3

—

(3039443) Prostate specific Ag panel - Serum or Plasma

581

0.84

0.56

1.7

1.6

—

(3043410) Blood group antigens tested for on Red Blood Cells

0.57

0.56

1.2

1.8

—

(1617658) Protocol used for examination of sentinel lymph nodes

195

0.72

0.56

1.0

—

(3001556) Androgen free Index in Serum or Plasma

1.62

0.55

1.0

1.2

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.58

0.54

2.5

3.3

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.50

0.54

26.3

8.1

—

(3007461) Platelets [#/volume] in Blood

3094

30750

1.07

0.54

32.0

19.5

e9/l

255.2

252.2

1.60

3042

30005

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

172

1578

1.09

0.54

2.2

1.9

—

(44806420)

1.45

0.53

2.2

2.4

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

1.43

0.53

1.0

1.2

99.8

106.6

0.22

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

118

1064

1.11

0.52

2.0

1.8

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

146

0.68

0.52

1.1

1.4

mmol/l

5.5

5.8

—

139

(3002256) Pathology report gross observation

358

3387

1.06

0.51

1.3

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

292

0.79

0.51

1.1

1.2

—

(3035941) MCH [Entitic mass]

3095

30769

1.07

0.50

31.8

19.4

30.2

30.3

1.01

3059

30362

(3024731) MCV [Entitic volume]

3095

30769

1.07

0.50

31.8

19.4

90.7

0.02

3060

30365

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

162

1.30

0.50

5.1

6.5

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

180

1.28

0.49

1.0

1.1

iu/ml

15.0

11.3

—

(3026361) Erythrocytes [#/volume] in Blood

3095

30772

1.07

0.49

32.0

19.5

e12/l

4.5

11.39

3028

29950

(3010813) Leukocytes [#/volume] in Blood

3096

30783

1.07

0.49

32.0

19.5

e9/l

7.0

6.7

7.23

3036

29955

(3025577) Chromium [Mass/volume] in Blood

146

1.30

0.47

2.1

ug/l

1.6

2.2

0.62

127

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2630

26051

1.04

0.46

4.6

4.3

mmol/l

6.0

5.9

1.25

2417

23935

(3003338) MCHC [Mass/volume]

2414

23871

1.04

0.46

27.8

16.8

g/l

332.5

332.9

1.60

2395

23682

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

458

1.16

0.46

7.0

3.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

1.38

0.46

2.6

2.4

—

(3033799) Differential panel - Peritoneal fluid

0.62

0.45

2.0

2.1

—

(3000963) Hemoglobin [Mass/volume] in Blood

3095

30782

1.07

0.45

32.2

19.6

g/l

133.8

136.4

18.05

3061

30374

(3005082) Progesterone [Moles/volume] in Serum or Plasma

121

0.66

0.45

1.1

1.3

nmol/l

25.0

31.7

—

101

(3001019) Free T4 and TSH panel - Serum or Plasma

148

1603

0.92

0.44

1.5

1.7

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2558

25812

0.96

0.43

4.0

3.8

mmol/l

1.4

1.3

3.76

2375

23891

(3003888) Timothy IgE Ab [Units/volume] in Serum

543

0.86

0.43

1.1

u/ml

13.2

5.1

1.29

291

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

144

1329

1.09

0.42

2.8

3.2

u/ml

36.8

50.7

0.85

139

1286

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

320

3041

1.06

0.42

1.4

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

765

1.11

0.42

1.2

1.1

u/ml

2.4

4.4

—

103

(4094501)

727

1.12

0.42

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.52

0.41

1.0

1.3

ng/l

155.4

106.6

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.52

0.41

2.6

2.2

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.52

0.41

1.0

1.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.41

0.0

1.1

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

1.2

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.40

0.0

1.4

—

15.6

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.40

0.0

1.0

—

(3032773) Endomysium IgG Ab [Titer] in Serum

238

0.80

0.40

1.0

1.1

—

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.1

—

1.5

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

0.00

0.40

0.0

11.6

—

197.7

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.36

0.40

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.31

0.39

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

1.31

0.39

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.31

0.39

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.31

0.39

1.0

1.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.39

0.0

1.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

124

1.29

0.38

1.2

1.0

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.39

0.38

2.6

2.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

345

1.16

0.37

1.1

1.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

657

1.11

0.37

1.3

1.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

112

0.71

0.37

1.0

1.5

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

365

0.85

0.37

1.1

u/ml

0.3

0.4

0.16

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.30

0.37

2.6

1.1

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

125

1.28

0.36

1.1

2.0

149.6

139.8

0.21

118

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

440

1.14

0.36

1.6

1.4

nmol/l

0.3

0.19

344

(40768795) Lymph node Pathology biopsy report

244

1.19

0.36

1.3

1.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

162

1.24

0.35

1.2

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

162

1.24

0.35

1.1

1.0

u/ml

0.1

3.6

—

(40761536) Microorganisms panel - Urine sediment

242

2304

1.05

0.32

5.7

3.9

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

239

1.17

0.31

1.5

27.1

33.3

0.44

150

(4034850)

878

1.08

0.31

8.7

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.30

0.30

1.3

1.2

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

184

1.20

0.30

1.2

1.1

u/ml

1.2

2.7

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

163

0.80

0.29

1.8

1.9

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

565

0.90

0.28

6.2

3.4

mg/l

23.6

26.4

0.19

354

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.29

0.28

2.3

1.4

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

1.27

0.27

1.0

1.4

109.1

104.9

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

258

0.85

0.27

1.2

1.4

pmol/l

60.3

173.1

—

(3015183) Erythrocyte sedimentation rate

159

1.20

0.26

1.2

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

178

1.18

0.26

1.5

1.4

u/ml

22.4

19.8

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.28

0.26

1.9

1.4

ug/l

9.9

8.9

0.27

(4133840)

0.69

0.26

1.2

1.1

—

(3037556) Urate [Mass/volume] in Serum or Plasma

0.67

0.25

1.2

1.3

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

463

1.10

0.25

1.3

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

888

1.07

0.25

1.5

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

330

1.12

0.25

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

503

1.09

0.24

1.6

1.7

—

(3050129) First trimester maternal screen panel - Serum or Plasma

848

0.93

0.24

1.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

311

3010

1.04

0.23

1.6

1.7

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

525

0.91

0.22

1.1

u/ml

2.1

1.3

0.49

227

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

144

1.18

0.22

1.8

2.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

596

0.92

0.21

1.1

u/ml

2.7

1.8

0.17

245

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.0

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

0.21

0.0

1.0

—

173.2

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

2.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.21

0.0

1.2

—

2.4

—

(40765089) Chromosome analysis panel - Blood by G-banded

101

0.79

0.21

1.0

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

497

4859

1.03

0.20

2.8

2.9

ug/l

0.7

0.67

326

3070

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.00

0.20

0.0

1.9

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

413

1.09

0.19

1.2

1.1

u/ml

2.9

2.7

0.06

193

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

323

0.90

0.19

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

1.22

0.19

1.0

1.3

83.6

89.6

—

(3004775) Volume in Urine collected for unspecified duration

195

1.13

0.17

1.9

2.2

664.6

628.6

0.17

131

(40768800) Prostate Pathology biopsy report

474

0.93

0.16

1.2

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

1.20

0.16

1.0

1.1

82.6

91.1

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

1.20

0.16

1.0

2.1

184.1

153.2

0.55

(4146454)

264

1.10

0.15

3.0

2.7

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

207

1.11

0.15

1.8

2.2

u/field

2.9

2.0

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

502

0.94

0.14

1.1

u/ml

4.5

2.4

0.41

126

(3014133) Dog dander IgE Ab [Units/volume] in Serum

430

0.93

0.14

1.1

u/ml

7.0

3.9

0.37

163

(3003694) ABO and Rh group [Type] in Blood

783

7734

1.02

0.14

1.4

1.5

—

(3044242) Glucose [Moles/volume] in Arterial blood

141

1.14

0.13

1.4

2.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

673

6646

1.02

0.13

3.7

4.0

20.7

21.5

0.66

291

3029

(3017569) Oxygen content in Arterial blood

123

1.14

0.12

2.0

2.4

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

200

1.10

0.12

16.0

14.6

nmol/l

707.2

833.8

0.50

194

(40768441) Liver Pathology biopsy report

200

1.10

0.12

1.5

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

181

1.11

0.12

1.0

—

(3020874) Milk IgE Ab [Units/volume] in Serum

181

1.11

0.12

1.2

1.0

u/ml

3.1

3.4

—

(3016750) Collection duration of Urine

153

1.11

0.11

2.0

2.2

min

518.2

497.5

0.30

112

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

177

0.90

0.10

1.3

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

555

0.95

0.10

1.3

1.4

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

1.14

0.10

3.2

1.3

nmol/l

0.3

0.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.13

0.09

2.1

1.7

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

126

1.11

0.09

1.0

1.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

1.09

0.08

2.7

3.2

ng/l

142.8

94.7

—

(3005033) Fetal Nuchal fold Thickness US

552

0.96

0.08

1.3

1.4

—

(40768793) Breast Pathology biopsy report

561

0.96

0.08

1.2

1.3

—

(3024263) Appearance of Synovial fluid

127

1.10

0.07

2.1

2.0

—

(3000012) Reticulocyte production index

127

1.10

0.07

1.3

1.6

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

133

0.90

0.07

1.2

1.4

—

(3022689) Creatine [Moles/volume] in Urine

0.82

0.07

1.2

1.4

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

184

0.92

0.07

1.2

1.3

—

1.5

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

698

7029

0.99

0.07

1.7

1.6

mmol/l

1.5

1.4

0.78

606

5969

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

163

0.92

0.07

1.4

1.5

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

150

1477

1.02

0.05

1.0

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

737

0.98

0.05

1.4

1.5

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

934

1.02

0.04

1.5

1.4

—

(4281824)

259

1.04

0.04

1.3

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

430

4279

1.01

0.03

1.5

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

571

0.98

0.03

1.4

1.5

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

370

1.03

0.02

1.4

1.6

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

388

0.98

0.01

2.2

3.0

u/ml

3.3

46.9

0.73

366

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

143

1.05

0.01

2.1

1.7

u/field

2.0

3.9

—

112

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

672

1.01

0.01

1.3

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

673

1.01

0.01

1.3

1.4

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

214

1.03

0.00

1.3

1.5

g/l

0.9

1.0

0.20

214

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

674

1.01

0.00

1.3

1.4

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

178

1774

1.00

0.00

1.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

103

0.97

0.00

1.1

1.0

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

675

1.01

0.00

1.3

1.4

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

395

0.99

0.00

1.1

u/ml

3.9

4.9

0.30

159

(1002224) Polysomnography panel

123

1227

1.00

0.00

1.1

—

(44813793)

183

0.98

0.00

1.1

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma

0.00

0.0

2.8

—

46.4

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

0.91

0.00

3.2

2.9

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.0

1.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.0

9.2

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.0

1.0

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.0

1.6

—

2923.3

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

0.0

1.0

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

1.02

0.00

1.5

1.1

u/ml

2.5

8.3

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.0

6.2

—

(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma

0.00

0.0

1.8

—

44.0

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

0.0

2.0

—

(3042301) Urate [Moles/volume] in Synovial fluid

0.00

0.0

1.0

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

0.0

1.3

—

(3044007) Cell count panel - Peritoneal fluid

0.93

0.00

1.4

2.4

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3020650) Glucose [Presence] in Urine

0.98

0.00

1.4

1.5

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

0.00

0.0

2.0

—

(3032333) Phosphate [Mass or Moles] in 24 hour Urine

0.00

0.0

1.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.96

0.00

1.0

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.3

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

0.00

0.0

1.4

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

0.0

1.0

—

1296.7

—

Mortality – FinRegistry

↥

Association

Association between endpoint G6_NEUINFL and mortality.

Females

Parameter	HR [95% CI]	p-value
G6_NEUINFL	2.497 [2.2, 2.84]	< 0.001
Birth year	0.996 [0.99, 1.0]	0.389

During the follow-up period (1.1.1998 — 31.12.2019), 1652 out of 7552 females with G6_NEUINFL died.

Males

Parameter	HR [95% CI]	p-value
G6_NEUINFL	2.74 [2.21, 3.4]	< 0.001
Birth year	0.983 [0.92, 1.05]	0.626

During the follow-up period (1.1.1998 — 31.12.2019), 1966 out of 7915 males with G6_NEUINFL died.

Mortality risk

Mortality risk for people of age

years, who have G6_NEUINFL.

N-year risk	Females	Males
1	0.258%	0.562%
5	1.414%	2.811%
10	3.869%	6.966%
15	7.369%	13.161%
20	13.182%	21.618%

Relationships between endpoints

↥

Index endpoint: G6_NEUINFL – Inflammatory diseases of the central nervous system

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Inflammatory diseases of the central nervous system

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints